Next Article in Journal
Resveratrol and Vitamin D: Eclectic Molecules Promoting Mitochondrial Health in Sarcopenia
Next Article in Special Issue
Vasorelaxant and Hypotensive Effects of Galla chinensis in Rats
Previous Article in Journal
TLR Agonists Modify NK Cell Activation and Increase Its Cytotoxicity in Acute Lymphoblastic Leukemia
Previous Article in Special Issue
Antimicrobial Potential of Pomegranate and Lemon Extracts Alone or in Combination with Antibiotics against Pathogens
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Urtica dioica: Anticancer Properties and Other Systemic Health Benefits from In Vitro to Clinical Trials

1
Department of Natural Sciences, Lebanese American University, Byblos P.O. Box 36, Lebanon
2
Department of Biochemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2024, 25(13), 7501; https://doi.org/10.3390/ijms25137501
Submission received: 9 June 2024 / Revised: 5 July 2024 / Accepted: 5 July 2024 / Published: 8 July 2024
(This article belongs to the Special Issue Health Promoting Benefits of Natural Products and Functional Foods)

Abstract

:
While conventional medicine has advanced in recent years, there are still concerns about its potential adverse reactions. The ethnopharmacological knowledge established over many centuries and the existence of a variety of metabolites have made medicinal plants, such as the stinging nettle plant, an invaluable resource for treating a wide range of health conditions, considering its minimal adverse effects on human health. The aim of this review is to highlight the therapeutic benefits and biological activities of the edible Urtica dioica (UD) plant with an emphasis on its selective chemo-preventive properties against various types of cancer, whereby we decipher the mechanism of action of UD on various cancers including prostate, breast, leukemia, and colon in addition to evaluating its antidiabetic, microbial, and inflammatory properties. We further highlight the systemic protective effects of UD on the liver, reproductive, excretory, cardiovascular, nervous, and digestive systems. We present a critical assessment of the results obtained from in vitro and in vivo studies as well as clinical trials to highlight the gaps that require further exploration for future prospective studies.

1. Background

Since the 20th century, technological advances in microscopy and chemical engineering, the emergence of highly resourceful pharmaceutical companies, the accessibility of novel sources for medicinal compound extraction, and the considerable increase in research and development spending have expanded the pool of available drugs [1,2]. However, even prior to the discovery of the microscopic world, primitive and ancestral forms of medicines predominantly relied on medicinal plants and their therapeutic properties.
To this day, plants have retained their place in both conventional and alternative medicines given the identification of their phytoconstituents with demonstrable benefits against various diseases [3]. As an alternative option, plants are relatively inexpensive, have remarkable chemical diversity, and circumvent cultural or religious controversies that would otherwise hinder the accessibility of primary care in the developing world [4]. One such plant is Urtica dioica (UD), better known as the nettle plant, common nettle, stinger, or stinging nettle. UD is a herbaceous plant of the Urticaceae family that belongs to a diverse taxonomic group, the details of which are outlined in Table 1 [5,6]. As for its nomenclature, the Latin name “Urtica” translates into “to burn”, whereas its common name, nettle, is derived from the Anglo-Saxon word “noedl” meaning needle. Fittingly, this flowering plant is characterized by stinging hairs, located on both the stems and leaves, that cause a burning sensation when rubbed against the skin. This irritation is majorly due to the release of a fluid containing acetylcholine, formic acid, acetic acid, serotonin, histamine, and leukotrienes among other substances responsible for this effect [2,7,8].
The use of common nettle in traditional medicine in the form of crude dried powder, tea infusions, decoctions, or fresh juices dates back several centuries [6,9]. However, modern interest has shifted to the use of UD extracts as therapeutic strategies since their pharmacological properties and chemical composition have been thoroughly assessed by several studies [10]. Although more work is required to understand the full extent of its therapeutic properties, the research conducted so far has attributed UD to several health benefits. For instance, the leaves of the nettle are highly rich in flavonoids, phenolic acids amino acids, saturated fatty acids, carotenoids, and organic acids (Figure 1) [11,12,13,14,15,16]. Previous research established that flavonoids, including rutin, luteolin, and quercetin, found in UD, possess anti-inflammatory and analgesic properties [17,18,19]. The former benefits auto-immune inflammatory disorders such as rheumatoid arthritis, rhinitis, and rheumatism, whereas the latter can limit oxidative damage, an important aspect of organ toxicity, malignant proliferation, and cancer progression [20]. Several bioactive molecules, including organic acids, namely formic, succinic, malic, and quinic acids, were shown to concentrate in the aerial organs of the plant, specifically the leaves more so than the stem or stalks [21,22]. Phytochemical analysis of the nettle leaves reveals the presence of several phenolic acid compounds: hydroxybenzoic acid derivatives (e.g., gallic, vanillic, syringic, protocatechuic, and gentisic acids) and cinnamic acid derivatives (e.g., cinnamic, caffeic, coumaric, ferulic, chlorogenic, and sinapic acids) [23]. As for the roots, their extracts contain fatty acids (polyunsaturated and monounsaturated fatty acids), lectins, sterols, polysaccharides, and lignans, which have been shown to improve the symptoms of benign prostatic hyperplasia, inhibit the proliferation and migration of cancer cells, and possess anti-angiogenic properties [5,16,24] (Figure 1). Even the seed oil of the nettle plant has been shown to carry antioxidative compounds such as fatty acids (linoleic and linolenic acid) and sterols such as β-sitosterol [25,26]. Interestingly, symbiotic endophytes such as Bacillus cereus or Bacillus mycoides, isolated from UD, have been identified as reservoirs of secondary metabolites, particularly polyphenols, with properties mirroring those of UD itself [27]. As a green plant capable of photosynthesis, its leaves and seed oil also contain chlorophyll and carotenoids such as β-carotene, violaxanthin, and xanthophylls, whose abundance is significantly influenced by the time of harvest [5,8,21,25,28,29]. Nettles have long been studied for their nutritional values, particularly for their substantially higher quantities of protein content relative to wheat and barley flours, as reported by a study conducted by Adhikari et al. (2015) [30]. The higher content of polyphenols contributes to the cleansing of the digestive system, improvement of bad breath and bloating, and detoxification of the liver [5]. Hence, from a nutritional standpoint, the leaves of UD are of great value due to their richness in water-soluble vitamins (vitamins B and C) and fat-soluble vitamins (vitamins A, D, E, and K) as well as their mineral composition including iron, calcium, magnesium, zinc, and soluble silica [8,10,19,31,32]. In fact, their introduction into animal diets has improved growth metrics and blood cholesterol levels [33,34]. Upon feeding nettle as forage to pregnant ewes, increased milk production and lamb growth along with a decreased rate of disease were observed [35,36]. The availability and preparation of UD for consumption were also investigated, revealing that the freeze-drying method results in better magnesium, phenolic, and antioxidant content when compared to convective methods [35]. However, amongst conventional forms of heat drying, convective or micro-wave drying of UD leaves displays distinctly lower energy consumption and higher color retention compared to other methods, such as vacuum drying [37,38]. Moreover, UD has also been reported to affect various other bodily function mechanisms, including reducing cancer symptoms, wound healing, cell repair, and the control of cardiovascular disorders [5,18,39,40]. It is also worthy of mention that the nettle plant can be used as a potential defense against pathogenic microorganisms, namely Gram-negative and Gram-positive bacteria [41].
Given all of these benefits and the eventual rise in demand for plant-derived therapeutic compounds for experimentation or consumption, the optimization of UD cultivation to prioritize yield and availability of bioactive molecules is incentivized. To that end, in terms of agronomical factors, proper weed management, uniform irrigation practices, and a supply of organic amendments for the soil were shown to be associated with a successful harvest [42]. Topographically, UD’s distribution extends across both lowlands and mountainous terrains, with a propensity for partially shaded areas. In parallel, fertile damp soil rich in nitrogen, whether weakly acidic or weakly basic, can accommodate the growth of UD, e.g., clay loam soil composition [21,42]. As for the harvest, the vegetation period, prior to flowering, remains optimal for the collection of UD leaves for therapeutic applications. Conversely, Paulauskienė et al. (2021) have suggested that variability in antioxidant capacity or composition between plants harvested at different stages of the vegetation period can be attributed to differences in meteorological conditions, including rainfall, temperature, and sunlight exposure [8,21]. Further, roots harvested in autumn, at the end of the vegetation period, have been shown to have a higher bioactive molecule content [42,43], while a positive relationship between increased exposure to sunlight and the phenolic content of individual UD plants has been shown [22]. Consequently, regions meeting these criteria produced UD harvests that exceeded others with respect to biomass, polyphenol content, and ascorbate levels [42]. Transitioning to the extraction process, brewing water extracts of UD at higher temperatures has been shown to elevate the antioxidant capacity of the final product [43], in contrast to ultrasound-assisted enzymatic extraction showing diminishing returns after raising the temperature past 60 °C [11]. In terms of solvents, alcohols, including methanol or ethanol, and water have been used in various combinations to maximize the retention of UD’s beneficial properties for therapeutic potential [11,12,13,14,20,43,44].
The purpose of this review is to provide a comprehensive and up-to-date assessment of the various therapeutic effects of Urtica dioica by reviewing its possible anticancer, antidiabetic, anti-inflammatory, antimicrobial, and analgesic properties as well as its systemic effects on the nervous, cardiovascular, reproductive, digestive, and excretory systems to contextualize various medical conditions for which the plant may be of use. Some reviews have focused on the promising antidiabetic potential [45], antioxidant properties [46], neuroprotective effects [47], and anti-tumorigenic role in breast cancer [48], in addition to the food functional properties of UD [23]. The body of literature in this review will be referenced in order to assimilate the leading hypotheses for the various effects of UD, reporting data from in vivo, in vitro, and clinical trials where applicable in order to identify the gaps necessitating further experimentation or clinical trials.

2. Anticancer Effect

In the past two decades, extensive studies reported the therapeutic potential of UD leaf and root extracts for the treatment of various types of cancers, with a major focus on breast tumor malignancy [48]. The following sections, summarized in Figure 2, assess the major developments in this area, whether in vitro or in vivo and highlight the gaps that require further investigation.

2.1. Prostate Cancer

Prostate cancer was the second most common malignancy in males globally with an increasing percentage of prostate cancer deaths worldwide in the 21st century [49]. A variety of therapeutic techniques were used for treatments, including traditional chemotherapy, radiation therapy, and surgical removal. However, the high mortality rate demonstrates the need to look into other therapeutic strategies. UD is one of various medicinal plants with therapeutic promise due to its proapoptotic activity in cancer cells [50]. The anticancer effects of the nettle plant on several prostate cancer cell lines have been examined as an alternative approach to traditional cancer treatments.
Different types of UD extracts including dichloromethane, methanolic, and aqueous extracts were evaluated and found to exhibit a cytotoxic effect on several prostate cancer cell lines, namely PC3 and LNCaP, in a dose- and time-dependent manner [50,51,52]. A differential response was observed on different prostate cancer cell lines depending on the hormonal sensitivity of each. In one study, researchers reported that DTH (3,4-divanillyltetrahydrofuran) extract from UD roots was more cytotoxic to LNCaP cells than PC3 cells due to their differences in androgen sensitivity [53]. UD was also shown to inhibit the proliferation of PC3 prostate cancer cells by inducing a G2/M cell cycle arrest, hence halting the cell cycle progression at a critical checkpoint during cell division [50].
Another mechanism for the anticancer effects of UD is the activation of the programmed apoptotic cell death mechanism. The molecular mechanisms through which UD extracts exhibit their anticancer activity range from reactive oxygen species (ROS) production, mitochondrial dysfunction, and DNA damage to proapoptotic caspase cleavage. UD extracts were proven to promote DNA fragmentation, one of the most fundamental aspects of apoptosis, in both PC3 and LNCaP cancer cells [50,51]. Additionally, studies indicated that UD extract activates the cleavage of poly ADP ribose polymerase (PARP), a protein involved in DNA repair, in the aforementioned prostate cancer cells [51,54]. Another hallmark of apoptosis is mitochondrial depolarization, which is characterized by increased permeability of the mitochondrial membrane and the release of cytochrome c, a caspase-9 activator, into the cytosol [55]. Levy and colleagues revealed in their study the ability of UD to decrease mitochondrial membrane potential in prostate cancer cells. Along with this, the authors confirmed increased caspase-3 and caspase-9 activity upon UD exposure, providing more evidence for the role of apoptosis in prostate cancer cell death [51], similar to another study that demonstrated an upregulated mRNA expression for both caspase 3 and caspase 9 in PC3 cells treated with UD [50]. Moreover, UD promoted inhibitory effects on the expression of the antiapoptotic marker Bcl-2, a protein that reduces the permeability of the mitochondrial membrane and inhibits the release of cytochrome c [50,56]. Lastly, the current literature indicates that there is a link between decreased mitochondrial membrane potential, ROS production, and apoptosis in cancer cells [57,58]. In the study conducted by Levy et al., the authors concluded that apoptosis activation, revealed by an increase in apoptotic markers along with DNA fragmentation and membrane depolarization, could be due to the accumulation of ROS in these cells upon exposure to UD as compared to the control group [51].
To the best of our knowledge, no in vivo studies have been reported in the literature evaluating the anticancer properties of UD on prostate cancer despite the extensive in vitro studies conducted. One ex vivo study, performed by Durak et al., assessed the ability of UD to halt prostate cancer progression in prostate cancer tissue extracted from patients; the authors noted a significant inhibition of the adenosine deaminase (ADA) enzyme, involved in the elimination of the toxic deoxyinosine molecule. As such, another mechanism that can explain the anticancer activity of UD is promoting cancer cell death via the accumulation of toxic metabolites [59]. Despite the promising data obtained from in vitro studies, further confirmation of the effect of UD in prostate cancer is needed from in vivo and clinical trials.

2.2. Breast Cancer

Several studies have revealed that UD exhibits antiproliferative properties along with proapoptotic effects on many breast cancer cell lines, including MCF-7 and MDA-MB cells. To analyze and evaluate those properties, Fattahi et al. reported a dose-dependent antiproliferative activity of UD extract on an MCF-7 breast cancer cell line along with a prominent antioxidant activity of powdered UD [60], which might be attributed to its flavonoid content, such as kaempferol, quercetin, and rutin content [61]. In the same study, the authors also elucidated the ability of UD to suppress MCF-7 cell proliferation via the activation of the apoptotic pathway: the mechanism was promoted via caspase-9 activation through calcium overload, which in turn triggers cytochrome c release from the mitochondria. As such, and through caspase 3, apoptosis is initiated by protein cleavage and membrane blebbing along with DNA fragmentation [60]. Similarly, UD was also found to promote the activation of apoptosis in MCF-7 cells upon increasing the levels of apoptotic markers, particularly the Bax/Bcl2 ratio [62]. Alternatively, Wenyua et al. (2021) suggested that by inhibiting the phosphorylation of PI3K/AKT pathway elements, UD is able to inhibit cell proliferation, decrease cancer cell viability, and induce cell cycle arrest at the G0/G1 phase, hence promoting apoptosis [63]. Additionally, the reduced expression of Ki-67 and increased expression of p53, which are regarded as a proliferation marker and a cell cycle regulator, respectively, have also been documented in breast cancer cells [64]. Recently, Upreti et al. (2023) evaluated the anticancer potential of UD on breast cancer cells in silico. Their results revealed a significant binding affinity of UD ligands with JAK2, which was then confirmed in vitro, confirming the selective cytotoxic effect of UD to be via the JAK2/STAT3 pathway, a constitutively expressed pathway in TNBCs [65].
From a different aspect, the inhibitory effect of UD on breast cancer cell motility was also assessed. UD was reported to have a selective and considerable ability to reduce the proliferation as well as the migration of MCF-7 cells while having no effect on an HFFF2 normal cell line [66]. The results are in line with another study that confirmed the efficacy of UD in inhibiting MCF-7 and MDA-MB-231 breast cancer cell migration. This was revealed by the downregulated expression of miR-21 genes; matrix metalloproteinases (MMP)-1, 9, and 13; E-cadherin; vimentin; and CXCR4, all of which play a crucial role in promoting cell metastasis. As such, the authors concluded that UD extract has the ability to halt the metastatic properties of breast cancer cells [66].
As for aggressive breast cancer cells, notably triple-negative MDA-MB cells, a number of studies provide significant data that could potentially deliver promising results for the role of the nettle plant in combination with chemotherapeutic drugs, a novel approach for better outcomes on patients’ health. Mohammadi et al. aimed to evaluate the potential use of UD with paclitaxel drug on triple-negative breast cancer (TNBC) cells, revealing its ability to enhance the sensitivity of MDA-MB to paclitaxel treatment. The authors suggested that this combination might promote cancer cell death via cell cycle arrest at the G2/M phase along with a downregulation of Cdc2 and wee1 expression, key regulatory factors of the cell cycle progression. Moreover, this combination had an inhibitory effect on the migration of the MDA-MB-468 cell line via the inhibition of Snail-1 gene expression, which is correlated with cell migration and metastasis [67]. These notions are in line with our own findings whereby a leaf infusion of UD similarly sensitized MDA-MB-231 cells to the chemotherapeutic drug, cisplatin, resulting in a dose- and time-dependent antiproliferative effect. The observed cell death was confirmed to occur via the activation of the intrinsic apoptotic pathway as revealed by the increase in the Bax/Bcl-2 ratio, DNA fragmentation, and PARP cleavage [68].
It is noteworthy that nanoparticles have emerged as drug delivery systems with a deeper reach than traditional chemotherapies. Their increased efficiency is also thought to reduce the reliance on larger dosages, with minimal toxicity on normal cells [69]. This is best exemplified in the recent work of Daglıoglu et al. (2023), where silver nanoparticles synthesized from UD leaf extracts exhibited dose-dependent antiproliferative and apoptotic effects on MCF-7 cells that far exceeded those of the extract alone [70], similarly to the selenium-based nanoparticles on a HepG2 cancerous cell line [69]. All of these findings combined emphasize the role of UD in the manufacturing of nanoparticles, with the aim of treating breast cancer among others.
Given the extensive basic studies conducted, the benefits of the nettle plant against breast cancer were also put into experimentation in in vivo studies. Using animal models and upon injection with UD extracts, tumor development and volume were found to be substantially decreased [64]; this is in line with the results obtained from the consumption of aqueous UD extract, which caused a lower incidence of breast cancer in mammary tumors generated in rats [71]. In another study, the authors reported the anticancer activity of UD on a BALB/c mouse model of breast cancer. Their data displayed a prominent decrease in tumor mass and size in the treated group, which, according to the authors, is due to the activation of apoptosis [72]. Translating these in vitro and in vivo studies into clinical trials is needed to further confirm the anticancer properties of the nettle plant and improve breast cancer patients’ health.

2.3. Blood Cancers (Leukemia)

Leukemia is a blood cancer that arises in the bone marrow and substantially leads to an abnormal leukocyte blood count [73]. Despite the available treatments like chemotherapy and radiation therapy, the need for novel and effective therapeutic strategies is evident. UD was shown to exhibit an antiproliferative effect on various leukemic cell lines. For instance, UD leaf extract demonstrated a significant inhibitory effect on the growth of HL-60, U937, and KG-1 cells in vitro [74,75,76] similar to the effect of UD agglutinin on Jurkat and Raji cells [77]. The selectivity of UD was further demonstrated by studies conducted on normal human B lymphocytes in our lab and PBMC cells treated under similar conditions, which revealed no significant cytotoxic effects [75,78]. Consequently, it could be deduced that UD might be a prominent and safe anticancer agent to be used for the treatment of leukemia.
A possible mechanism of action for UD is targeting the cell cycle progression. In fact, UD extract caused a time- and dose-dependent increase in pre-G0 content in U937 cells [75], while displaying an increase in the sub-G1 phase in HL-60, Jurkat, and Raji cells [74,77]. Along with these results, exposure to UD extracts resulted in a remarkable downregulation of genes involved in the cell cycle pathway, such as the MDM2 gene [78].
Hallmarks of apoptosis were further investigated to elucidate the mechanism by which UD disrupts the proliferation of leukemic cells. Flow cytometry results from various leukemia cell lines treated with UD showed a significant increase in Annexin V binding to phosphatidylserine upon the translocation of the latter to the outer leaflet during apoptosis [74,75,77,78]. Along these lines, our lab quantified DNA fragmentation and reported a significant increase in the enrichment of oligo-nucleosomal fragments in U937 cells [75]; activation of the mitochondrial-dependent pathway of apoptosis was further demonstrated by the significant increase in the Bax/Bcl-2 ratio. Moreover, the mitochondrial membrane potential, a key indicator of healthy intact mitochondria, was found to be responsible for promoting cell death in HL-60 cells [74]. Disruption in this potential could have detrimental outcomes and commit the cells to the apoptotic pathway. Other crucial regulators of apoptosis are PARP genes involved in DNA repair, particularly PARP2, which was downregulated in HL-60 cells exposed to UD extract, thereby promoting the activation of apoptosis. On the other hand, it should be noted that PARP4 can exhibit opposing effects. Interestingly, agglutinin from UD was reported to inhibit HL-60 cell growth via the upregulation of PARP4 expression [78]. The involvement of both extrinsic and intrinsic pathways was put into evidence by the activation of caspases 3, 8, and 9 along with an increase in the Bax/Bcl-2 ratio and other proteins such as p53 and p27 [74,77]. Moreover, UD extract could exhibit cytotoxic effects on leukemic cells by targeting various cellular mechanisms such as the IGF1/IGF1R signaling pathway, known to be a key factor in the progression of many cancers, especially acute myeloid leukemia [78]. UD agglutinin extract was also found to significantly promote apoptosis in Jurkat cells while exhibiting a non-significant effect in Raji cells. This resistance to apoptosis was examined by Kawabata et al. (1999), reporting a lack of caspase activity [79]. Additionally, Luciano et al. (2002) corroborated this finding by detecting a low ratio of DFF40 to DFF45, signaling the absence of DNA fragmentation [80]. Further studies should elucidate the mechanism behind this resistance while also conducting further experimentation on animal models and in clinical trials to better understand the ability of UD to halt the progression of leukemia.

2.4. Colorectal Cancer

The prevalence of colorectal cancer, known to be a common type of digestive malignancy, is still on the rise despite the universal use of conventional treatments, pushing the scientific community to thoroughly investigate alternative approaches [81].
Most of the literature targeted the human colon carcinoma HT29, colorectal carcinoma HCT116, and the colon adenocarcinoma Caco-2 cell lines to investigate the anticancer properties of UD. Nettle plant extract was shown to significantly inhibit the proliferation of these cell lines in a dose- and time-dependent manner, with minimal effects against healthy human colorectal cells (HFF) [81,82,83], highlighting its promising potential use amongst other treatments. Furthermore, there is compelling evidence that oxidative stress is a mediator of apoptosis [84,85]. With that in mind, UD, through the mediation of lipid peroxidation, has been reported to increase ROS content, promoting oxidative stress [86,87]. At the same time, other studies have documented cell cycle arrest at the G2 phase and DNA fragmentation upon UD treatment [81]. Combined, these aspects suggest the ability of UD to induce an apoptotic response in colorectal cancer cells. To support this conclusion, Kardan et al. (2020) highlighted the selective cytotoxic effect against healthy HDF epidermal cells [83]. As an extension, following UD treatments, the mRNA and protein expression of Caspases 3 and 9, as crucial markers of apoptosis, was increased, the mRNA expression of the antiapoptotic Bcl-2 protein was decreased, and the ratio of Bax/Bcl-2 was elevated [81,83,88]. However, Ghasemi et al. (2016) recognized that the precise signaling pathway behind such results remains elusive given the diversity of compounds within Urtica dioica extracts, including isolectins, phenols, and triterpenoic acids [86].
As for other properties, UD has been documented to exhibit chemo-preventive effects when supplied simultaneously with a tumor inducer in animal models. Specifically, UD supplementation reduced colon cancer incidence rate and development, restored the activities of several antioxidant enzymes, and induced apoptosis through elevated Caspase 3 expression [88]. In addition, advancements in nanotechnology, namely nanoemulsion and nanoencapsulation, have risen to prominence in the medical field due to their increased bioavailability, controlled release, and increased specificity. As it relates to colon cancer, both UD nanoemulsion and nanoencapsulated UD extract showed increased antiproliferative effects against HCT-116 as compared to a hydroethanolic extract [89]. In light of the established basic research studies, UD extracts might be a promising option for additional clinical research and alternative therapies.

2.5. Other Types of Cancer

The promising anti-tumor effects of UD on other types of cancer, including cervical, gastric, and lung cancer, have also been reported in the literature [48,86,90]. However, combination therapies have been recently extensively investigated; the detrimental side effects of chemotherapeutic agents have resulted in a strong incentive to find novel ways to increase the efficiency of these treatments without resorting to higher dosages. One such method is the reliance on combination therapies utilizing natural compounds. Two types of cancers that have been investigated in this respect are bladder cancers and non-small cell lung carcinoma (NSCLC). The combination of an N-butanol UD extract and doxorubicin, a drug used in the treatment of bladder cancer, among other types, exceeded the apoptotic effect of each drug alone on T24 bladder cancer cells [91]. In the case of NSCLC, which responded poorly to cisplatin treatment, UD displayed a selective antiproliferative effect with no harmful effect on normal cells. Interestingly, co-treatment exhibited a synergistic anticancer effect by promoting the activation of apoptosis via the extrinsic pathway in addition to an arrest in the cell cycle at the G2/M phase [92]. This is in line with the promising results of combination therapies that have been reported previously in breast cancer cells, as elaborated above. Moreover, the combination of UD extracts with other medicinal plants has also yielded promising results. Specifically, Rahmani et al. recently showed that the combination of UD and Wormwood (Artemisia absinthium), as a hydroethanolic extract, had a more prominent anticancer effect on HCT-116 cells compared to each alone [89]. Given the extensive body of literature and studies demonstrating the anticancer properties of UD extracts on various cancer types (Table 2), the nettle plant provides a promising chance for its use in cancer prevention and treatment to improve the survival rate of patients.

3. Antidiabetic Effect

Diabetes is a severe metabolic illness that affects people from all backgrounds of life, regardless of geography, ethnicity, or race, and its incidence and prevalence are increasing at an alarming pace internationally [93]. Ethnobotanical data suggest that over 800 plant species, including UD, are believed to possess antidiabetic properties, as reported in many in vivo studies [94,95,96].
A study conducted by Patel and Udyabanu (2014) investigated the antidiabetic properties of a hydro-alcoholic extract of UD on dexamethasone-induced diabetic mice. Their data demonstrated that UD effectively normalized elevated blood glucose levels, reduced body weight, and attenuated increased water intake induced by Dexamethasone exposure, a glucocorticoid receptor agonist [97,98]. Congruent results were noted to ascertain the antidiabetic effect on Streptozotocin (STZ)-induced type 2 diabetic mice based on weight loss prevention and improvements in fasting blood glucose and insulin levels [99,100]. Several studies further elaborated on the UD extract mechanism of action, indicating that it increases β-cell insulin secretion and hepatic glucokinase, hexokinase, and glucose-6-phosphate dehydrogenase enzymes [100,101,102]. Similarly, Pérez Gutiérrez et al., who recently investigated the effects of the orally administered extract combination of UD comprising Apium graveolens and Zingiber officinale (UAZ) on diabetic mice, reported an improvement in hepatic enzymes and a reduction in liver weight, which reveals the hypolipidemic and hypoglycemic effects of UD [103].
Interestingly, a study conducted on type 2 diabetes mellitus patients reported that UD can decrease the risk of cardiovascular diseases as they observed an increase in high-density lipoprotein (HDL) [104]. Furthermore, Fan et al. (2020) corroborated the protective role of UD in preventing insulin resistance in high-fat-diet mice (HFM) via significantly reducing adipocyte fat accumulation [105]. Moreover, HFM mice treated with UD exhibited lower levels of CD11c, an inflammatory marker associated with insulin resistance, compared to low-fat-diet mice, while it significantly increased the fasting-induced adipocyte factor, which reduces the ability to store fatty acids in peripheral tissues.
Chronic hyperglycemia itself can dysregulate many of the body’s vital processes, potentially leading to cardiomyopathy, which is characterized by an increase in PGC-1α and NRF2, key regulators of cardiac mitochondrial biogenesis. As such, Seyyedeh et al. recently aimed to elucidate the impact of UD supplementation, in conjunction with an endurance training protocol, on various metrics of cardiac function in STZ-induced diabetic mice [106]. The results revealed the ability of the extract to increase ATP content, citrate synthase activity, and the expression of PGC-1α as well as that of NRF2. Additionally, Mehrezi et al. discovered that UD extracts can also increase antioxidative enzymes, such as superoxide dismutase, while reducing oxidative stress biomarkers, including thiobarbituric reactive species and lipid hydroperoxides [104]. Furthermore, recent investigations highlighted the neutralizing effect of UD bioactive compounds on ROS production in insulin-secreting β-cells, thereby preventing oxidative stress-induced diabetes [107]. In vitro studies reported the inhibitory effect of UD on the enzymatic activity of α-amylase and α-glucosidase, thus reducing glycemia [108]. This is in line with the data of another study conducted by Rahimzadeh et al., whereby UD promoted a noticeable inhibition of maltase, sucrase, and lactase activities [109].
In the case of insulin resistance, muscle and adipose are unable to translocate GLUT4, a facilitative hexose transporter, to the cellular surface, contributing to an aberrant glucose homeostasis [110]. The exposure to UD extract increased GLUT4 translocation to the cell surface compared to the control group, reaffirming the antidiabetic properties of UD. This aligns with the previous work reporting the effect of UD extract in reversing the decrease in Hippocampal GLUT4 mRNA expression [97].
Interestingly, the antidiabetic potential of UD has further been confirmed in several clinical trials in patients suffering from type 2 diabetes [111]. Nettle leaf extract was effective in lowering blood levels of fasting glucose and glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes as compared to a placebo group, with no effect on creatinine, liver enzymes, or blood pressure [112]. Along with this, a recent investigation also reported a positive effect of UD extract on type 1 diabetes; the intervention group had lower blood glucose and total insulin levels, which further expands the antidiabetic properties of UD [113,114].

4. Antimicrobial Effect

The use of natural plant-derived antimicrobial compounds for food preservation has become crucial. The overuse of antibiotics and antifungal drugs has adverse health reactions, which might lead to drug resistance [115,116,117]. Furthermore, viral mutations have rendered many of the traditional antiviral drugs and vaccines less effective [118]. For these reasons, the use of natural plant-derived extracts such as UD has become increasingly significant in treating bacterial, fungal, and viral infections [116].
Several studies were conducted to investigate the potential antibacterial effects of UD on inhibiting the growth of Gram-negative and Gram-positive bacteria, suggesting its promising effect in pharmaceutical as well as food industries [69,119]. It was also reported that UD methanolic extract had a considerable antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA) isolates [120]. This was further demonstrated by the topical application of ointment made from UD to accelerate the wound healing process by preventing bacterial colonization by MRSA [121]. In addition, when UD was used in wound dressings along with zinc oxide, medical scaffolds became much stronger against Staphylococcus aureus and Escherichia coli [122]. One study revealed that the essence of UD leaves significantly inhibited the growth of Klebsiella pneumoniae and Bacillus cereus. However, the essential oils only exhibited an average inhibitory activity on Staphylococcus aureus and Pseudomonas aeruginosa [123]. Numerous other studies have also confirmed the antibacterial properties of UD on other bacterial species including Bacillus subtilis, Shigella dysenteriae, Salmonella typhi, Pseudomonas fragi, Campylobacter jejuni, and Listeria monocytogenes [69,115,124,125,126,127]. It is important to note that UD extract did not cause any adverse effects on non-pathogenic bacteria such as the beneficial bacteria Lacticaseibacillus and Bifidobacterium [128]. In addition, UD was reported to work synergistically with other drugs and natural compounds such as tetracycline, erythromycin, and chloramphenicol by decreasing the minimum inhibitory concentration (MIC) of these drugs in the treatment of Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae [129]. The molecular methods by which UD exerts its antibacterial properties have also been investigated, suggesting its ability to disrupt bacterial cell structure and phosphorus metabolism, leading to cellular material leakage into the environment, hence promoting bacterial death [116].
Looking further into the antimicrobial properties of the nettle plant, many studies have explored its antifungal and antiviral activity. In one study, selenium nanoparticles (SeNP) synthesized using UD revealed antifungal properties against unicellular and multicellular fungi including Candida albicans, Aspergillus fumigatus, Aspergillus niger, Aspergillus flavus, and Candida lipolytica [69,115,129]. In a similar investigation, researchers reported the significant antifungal effect of UD against Candida albicans and Candida parapsilosis despite the stronger effect of the antifungal drug amphotericin B [117]. Furthermore, the antiviral effect of UD was assessed against the SARS-CoV-2 virus, confirming its inhibition of virus entry, replication, and infectivity [130,131,132]. The inhibitory effect was found to be due to the ability of UD to block angiotensin-converting enzyme 2 (ACE2), a receptor that is required for the attachment and entry of the SARS-CoV-2 and Rabies viruses into the cell [118,133].
Interesting research on UD’s antimicrobial and antiparasitic benefits was evaluated using in vivo models. A study conducted by Badirzadeh et al. reported that nettle plant extract can decrease the number of parasites in cutaneous leishmaniasis, an opportunistic disease in HIV-infected individuals. It is also important to note that interferon (IFN)-gamma levels were increased after injection with the extract, while the number of macrophages remained the same. The study shows the effectiveness of UD in targeting parasitic infections in mice while also being harmless to macrophages and inducing beneficial immune mechanisms [134]. Along with this, another study focused on the effect of UD on mice with toxoplasmosis, a parasitic infection caused by Toxoplasma gondii. In this study, UD-treated mice had a higher survival rate, decreased number of brain cysts, and increased levels of INF- γ [135]. These results together, summarized in Table 3, confirm the antimicrobial properties of UD against bacterial, viral, and fungal infections.

5. Anti-Inflammatory Effect

Various studies investigated the promising effect of UD on treating inflammatory conditions due to its flavonoids and phenolic acids content, which can lower the synthesis of inflammatory mediators [136]. Hence, UD has been utilized in world traditional medicine for treating anemia, dermatitis, and joint pain for hundreds of years [90].
Tumor necrosis factor (TNF) levels are elevated in numerous inflammatory diseases and may be responsible for the increased expression of some proinflammatory genes. In vitro studies reported the effect of nettle leaf extract in inhibiting TNF-kappa activation in several cell types, namely human T lymphocytes, macrophages, and epithelial cells [137]. Nettle extracts were also evaluated for their ability to reduce the levels of Interleukin (IL)-1β-induced Nuclear Factor Kappa Beta (NF-κB). NF-κB is a transcription factor that enters the nucleus and stimulates the production of proinflammatory and proapoptotic genes. The extracts of nettle were able to suppress the NF-κB signaling pathway and block the translocation of activated NF-κB to the nucleus in chondrocytes [138]. The anti-inflammatory effect of UD was also investigated using macrophage immune cells (RAW264.7); it was reported that methanolic extract preparation from the flowering part of the nettle plant promotes a prominent anti-inflammatory effect with minimal cytotoxicity when compared to other extract preparations from different plant parts [139]. Another study showed that stinging nettle also exhibits anti-inflammatory properties by blocking the enzymes cyclooxygenase and lipoxygenase, which produce the proinflammatory mediators prostaglandins and leukotrienes, respectively. Their data also demonstrated that an alcoholic UD extract can lower the concentrations of TNF-α and IL-l, two proinflammatory cytokines whose release in the blood is induced by lipopolysaccharides [140]. These findings have been translated into clinical studies that revealed the anti-inflammatory effect of UD in patients with inflammatory bowel disease and rheumatoid arthritis [141,142]. Moreover, a double-blind clinical trial reported no major effects of UD root extract in reducing inflammation of allergic reactions as compared to the placebo; however, the authors underscored the major limitation of their findings being the limited sample size in addition to the need for longer-term studies [143].

6. Analgesic Effect

Despite the pain relief offered by opioids, non-steroidal anti-inflammatory medicines (NSAIDs), antispasmodics, calcium channel blockers, and antihistamines [144], the negative side effects associated with their long-term use remain a point of contention. In this aspect, the available data present UD as a reasonable alternative, whereby it has been reported that UD exhibits analgesic effects in acetic acid-induced writhing and formalin tests, with the former widely employed for analgesic drug screening [136,144]. As for the latter, UD was shown to reduce the pain response in the phase correlated with an inflammatory response, suggesting that the observed analgesia stems from the previously described anti-inflammatory action of UD [145]. In accordance, an aqueous extract of nettle leaves and stems conferred resistance to thermal stimulation in mice models. Together, these findings point to analgesic activity in the peripheral nervous system partly due to the presence of flavonoids, caffeoyl malic acid, and caffeic acid among others [31,145]. On the other hand, nettle leaves, when applied externally, possess similar analgesic properties. In particular, participants in a study conducted by Randall et al. (1999) unanimously reported improvements in their joint discomfort/pain after applying fresh UD leaves to their body [146]. A following randomized control trial revealed similar reductions in wrist pain following UD application to the area of interest [146].

7. Systemic Effects

In addition to the various therapeutic effects detailed above, the literature further confirms the protective effects of UD on various organ systems in the human body, which are all summarized in Figure 3 and further elaborated in the following sections.

7.1. Hepatoprotective and Anti-Toxic Effects of UD

The liver is the second-largest solid organ and one of the most important organs of the human body for the regulation of homeostasis. It eliminates contaminants and other toxins from the body’s blood supply, controls blood coagulation, and performs numerous other vital functions [147]. Aside from the numerous synthetic medications that are accessible, several forms of natural and herbal remedies derived from plants, including UD with its phytoconstituents, are used to treat liver illnesses. For instance, a large dose of cisplatin, a chemotherapeutic agent, has been linked to nephrotoxicity and hepatotoxicity. As a consequence, Ozkol et al. (2012) investigated the hepatoprotective effects of UD methanolic extract against cisplatin toxicity in Erhlich ascites tumor (EAT)-bearing mice. They demonstrated the protective effect of this extract of enhancing the antioxidative defense systems and minimizing the deleterious impacts on the liver [148]. The same hepatoprotective effect extends to other harmful compounds, namely ethylene glycol, previously shown to damage hepatic tissue. Interestingly, UD was shown to minimize inflammatory cell infiltration as part of its improvement of hepatic histopathology [149]. Moreover, scientists recently aimed to investigate the radioactive protective activity of UD seed extract in the whole blood and liver of radiation-administered rats. The radiation group exhibited an increase in the levels of 8-hydroxy-2-deoxyguanosine (8-OHdG), a biomarker for endogenous oxidative DNA damage [150], and a reduction in Gpx-1 immunoreactivity, which prevents ROS production. However, an amelioration in those parameters was observed in the radiation group treated with UD [151,152]. In parallel, Yıldızhan et al. concluded that UD prevented radiotherapy-induced liver damage as well as lipid peroxidation and oxidative stress, in addition to the protection of antioxidant enzymes. Overall, these results highlight the potential role of UD as a radioactive protector [153]. Furthermore, the injection of rats with UD resulted in a significant choleretic effect, the stimulation of bile secretion from the liver, the synthesis and excretion of cholates, and, finally, bilirubin and cholesterol excretion [154].
Heavy metals, if found in high amounts in the soil, tend to bioaccumulate in vegetables, which are eventually consumed by animals and humans. Even though metals like copper and zinc are essential nutrients for humans, at high concentrations, they might cause numerous diseases, including cardiovascular diseases, arteriosclerosis, gastrointestinal immunity disorders, and even neurodegenerative illnesses [155]. Multiple studies investigated the beneficial effects of UD, particularly on heavy metal toxicity [156]. Recently, an in vivo study on copper sulfate-poisoned rats treated with UD reported a significant decrease in kidney weight, glucose, uric acid, urea, creatinine, triglycerides, and LDL alongside a significant increase in body weight and HDL, with no significant alterations in cholesterol and VLDL levels [157].
From a different aspect, inflammation of pancreatic and peripancreatic tissues can be partly traced back to the secretion of inflammatory cytokines or the release of free radicals, which both induce hepatocyte apoptosis. In this respect, Yılmaz et al. demonstrated that UD improved edema, pancreatic necrosis, and pancreatic inflammation in a TNF-α-independent manner while reducing apoptosis [158]. In conclusion, these studies incorporate UD’s various aforementioned modes of action in toxicity prevention and hepatoprotection.

7.2. Effect on the Nervous System

The presence of the blood–brain barrier, the interconnectivity of different molecular pathways, and the risk of unintended side effects arising in the same or distant structures constitute some of the limiting factors halting the progress in the treatment of CNS diseases [159,160]. Hence, alternative sources of bioactive molecules that can circumvent these criteria are a valuable substitute for traditional medications [161,162]. Urtica dioica contains various compounds, including scopoletin, 5-hydroxy tryptamine (5-HT), and carvacrol [34], which were reported to promote potentiation within the hippocampus, contribute to memory formation, and possess neuroprotective properties, respectively [163]. Consequently, this positions UD as a prime candidate for the treatment of diabetes-induced neuropathy, cognitive decline, neurodegenerative diseases, or depression, leading to the successful clinical studies that have been recently reviewed by Semwal et al. [47].
Fundamentally, inducing type 2 diabetes is expected to detrimentally alter both insulin signaling pathways and ROS levels in the hippocampus, contributing to a depressive-like phenotype in mice models [97,99]. Interestingly, it was shown that UD treatment improved insulin signaling through the mediation of insulin receptor and insulin-like growth factor-1 receptor (IGF1R) levels, reduced oxidative stress, and opposed neuroinflammation and apoptosis [99]. To be specific, UD treatments improved various biomarkers including malondialdehyde (MDA), thiobarbituric acid-reactant substances (TBARS), superoxide dismutase (SOD), and catalase activity, highlighting a potential neuroprotective role for UD in combatting neuronal cell death [97,99,164]. Recent studies also established that UD increases the expression of neurotrophins NGF and GAP-43, improves the activity of antioxidant enzymes GPx and GSH, reduces karyopyknosis within hippocampal tissue, and builds up neural-microglial density [165,166,167] within the aging brain, expanding the suggested role of UD to include the promotion of neurogenesis and neural plasticity in the hippocampus. All the while, UD was able to counteract diabetes-induced cognitive decline, rescue depressive-like behavior, and improve both spatial and associative memory [97,99,165]. Interestingly, the data suggested that the combination of UD and moderate exercise produced more prominent results, and it was able to reduce TNF-α, restore insulin levels, or increase BDNF expression in aging brains when UD or exercise alone could not [99,167].
Notably, improvements in anxiety/depressive-like behaviors have been documented after similar changes in oxidative stress markers within other brain regions, namely the prefrontal cortex and midbrain [162,166,168]. Transitioning toward the peripheral nervous system, Patel and Udayabanu (2013) determined that UD treatment could improve the hypoalgesia, or loss of pain sensation, to multiple types of stimuli, which is associated with diabetic peripheral neuropathy, noting Scopoletin as the causative agent [163,169]. With respect to neurotoxicity, UD was shown to decrease the abundance of histopathological lesions within the cerebrum and cerebellum in rabbit models, which are a defining feature of ethylene glycol poisoning [170].
As for conditions affecting motor function, UD extracts displayed antiepileptic effects due to the presence of flavonoids, which are thought to mediate convulsions through the GABAergic system [171]. Moreover, recent work by Manville et al. (2023) reported that UD components, namely gallic acid and tannic acid, can be used in the treatment of Episodic Ataxia based on their ability to ameliorate the activity of mutated Kv1.1 voltage-gated potassium channels [172]. Another condition, ischemic stroke, has also shown promising results following UD pre-treatments in mice models. In particular, XBP-1 splicing, a key process in unfolded protein response, was reduced, suggesting a prophylactic neuroprotective effect [173]. This highlights a dual role of UD in the mediation of ER stress, as other studies have linked similar treatments to the activation of apoptosis through GADD153 and increasing ER stress in cancerous cells [92].
With respect to Parkinson’s disease, recent findings demonstrated the efficacy of UD treatments in increasing the autophagic removal of α-synuclein deposits, reducing the number of Lewy bodies, and normalizing oxidative stress as a means to reduce apoptotic loss of dopaminergic neurons [168]. Concurrently, as it pertains to Alzheimer’s disease, UD root extracts were shown to improve levels of dopamine, norepinephrine, and serotonin; normalize the levels of ATP; mend memory deficits; and protect against Tau accumulation in the cortical region of the brain [166]. Combined, these results highlight the ability of UD extracts to counteract the factors contributing to neurodegenerative phenotypes. The neuroprotective activity of UD, from preliminary evidence to clinical trials, has been recently assessed by Semwal et al. [47].

7.3. Effect on the Cardiovascular System

Among the many addressed uses of Urtica dioica is its potential use in treating cardiovascular diseases. Earlier studies assessed its hypotensive action and reported a vasorelaxation response in vitro [174]. In parallel, using rats as test subjects, Legssyer et al. investigated the cardiovascular effects of UD and confirmed similar hypotensive results. After the injection of UD extract, the heart rate decreased, and the left ventricular pressure increased [175]. These results are contradictory to the main conclusion of their study; yet, according to the researchers, what accounts for the decrease in vascular pressure after UD injection is the bradycardia, a heart rate of fewer than 60 beats per minute [176] induced by the extract through non-adrenergic pathways, which compensate for the increase in pressure and lead to a hypotensive action that only occurs in vivo. Concurrently, data have also shown that UD extracts display anti-hypertensive properties given its angiotensin-converting enzyme (ACE) inhibition activity, which was linked to the prevalence of antioxidative compounds [13]. These findings suggest a dual role of UD in the maintenance of optimal blood pressure.
Hyperlipidemia, which refers to an excess of lipids or fat in blood, is a major cause of hepatic damage [177], and, there also, a protective effect was observed when Urtica extracts were introduced in animal models. The consumption of a UD aqueous extract by albino rats in vivo normalized the atherogenic lipoprotein phenotype and decreased total and LDL cholesterol levels specifically without having any impact on HDL cholesterol levels. The researchers concluded that UD can be used to avoid cardiovascular diseases such as hyperlipemia and any other disease associated with high LDL cholesterol levels [178].
Thrombosis and atherosclerosis are major cardiovascular diseases that are directed by platelet hyperactivity. UD has been shown to play a role in platelet aggregation; El Haouari et al. demonstrated that, after the in vitro treatment with Urtica extracts from different parts of the plants, the thrombin-induced aggregation was inhibited to various extents. This is a potential lead in using the plant to treat atherosclerosis, a main cardiovascular disease that claims a large number of victims [179]. Moreover, arteriosclerosis may be caused by oxidative stress due to the presence of free radicals. Along these lines, a recent study by Uğur and Güzel (2023) reported the efficacy of UD extract in limiting the free radical damage either by inhibiting the free radical activity or by acting as an antioxidant, hence providing major protection against arteriosclerosis [44].

7.4. Effect on the Reproductive System

Natural plant-derived extracts can play a significant role in hormonal regulation and overall fertility in treating conditions of the female reproductive system, including polycystic ovary syndrome (PCOS) [180]. Experimentally, dehydroepiandrosterone (DHEA)-induced PCOS mice models were used to assess the impact of UD and Lutein, a dietary carotenoid, on fertility. UD exposure was reported to decrease lipid peroxidation, increase total antioxidant capacity, normalize estrogen levels, and improve several metrics of fertility, including fertilization rates and oocyte quality. Notably, the combination of lutein and UD extract exceeded the effectiveness of each treatment individually in every observed metric except the number of oocytes and embryos [181]. In a similar study, DHEA-induced PCOS in mice was treated with a combination of UD and chamomile extract. The researchers observed that these extracts can be an effective supplement in the treatment of the symptoms of PCOS as it led to an increase in the number of normal follicles, a decrease in the number of cystic follicles, and improved overall folliculogenesis [180]. Additionally, in two other studies, UD herbal extract was able to reduce the negative impacts of retinoic acid on oocyte maturation in both in vivo and in vitro models [182,183]. The ethanolic extract of UD also exhibited pro-fertility activity, along with protective effects on ovarian cells against oxidative stress, as revealed by increased catalase activity, a major in vivo antioxidant biomarker [184]. The nettle plant is known to possess various compounds that function as aromatase inhibitors, a characteristic that has been proposed to explain its amelioration of hormonal balance. The enzyme aromatase catalyzes the conversion of androgens to estrogen [181]. This phenomenon is particularly noticeable in age-related reproductive disorders, whereby treatment with nettle powder reversed several hallmarks of sexual dysfunction in aged quails, including the estradiol/testosterone ratio, the FSH/LH ratio, egg thickness, fertility, and embryonic mortality rates [185]. Moreover, another randomized clinical trial confirmed the promising ability of UD to decrease hot flashes symptoms in menopausal women [186]. According to the European Union Herbal monograph on Urtica dioica, pregnant women should refrain from using UD during their pregnancy due to its ability to stimulate uterine contractions [187,188]. Moreover, it was also established that topical use of UD while breastfeeding can cause urticaria, an allergic skin rash on the mother’s skin and her breastfed infant [189]. From a different perspective, scientists also investigated the potential inhibitory effect of UD on nicotine-induced adverse implications on sperm parameters: when compared to the control group, UD significantly improved testosterone levels, seminiferous tubules diameter, and sperm cell morphology, motility, and count [190]. Taking these results together, the nettle plant is considered beneficial in ameliorating both male and female reproductive systems.

7.5. Effect on Digestive System

The protective effect of UD on the digestive tract was evaluated and confirmed on various gastrointestinal diseases using various models, such as mice with Dextran sulfate sodium (DSS)-induced colitis and ethanol-induced ulcer models [191,192]. This protective effect was further evaluated in a study conducted by Dakhli et al. (2023), reporting reduced DSS-induced ulcerative colitis in rat models treated with UD aqueous extract. This colo-protective effect might be attributed to its ability to reduce oxidative stress by lowering the MDA/H2O2 production, stimulating the effect of antioxidant enzymes, and reducing inflammation by decreasing CRP levels [193]. Colitis is a chronic inflammatory digestive condition of the colon’s inner lining, commonly recognized by measurement of fecal IL-1β and mucosal TNF-α. UD extract was found effective in reducing colitis clinical signs, as revealed by the significant reduction in inflammatory markers IL-1β and TNF-α in treated animals [192].
Addressing the intestinal flora, Fan et al. (2021) reported that UD improves gut microbiota, particularly the composition of Clostridia. Moreover, metabolic function prediction showed that UD enriches amino acid metabolism pathways that contribute to reducing body weight and increasing insulin resistance [194].
From a clinical standpoint, supplementation with a highly standardized formula containing UD, other botanical extracts, and mannitol dry extract decreased the water content in female participants with high and moderate extracellular water, while it also decreased the fat mass of those participants [195]. Furthermore, dried hydroethanolic nettle leaf extract administered to participants led to a significant reduction in high-sensitivity CRP serum levels as well as platelet count. An increase in superoxide dismutase, an enzyme responsible for free radical elimination, was also observed upon UD supplementation along with an overall health improvement in patients suffering from a coexisting inflammatory bowel disease [196].

7.6. Effect on the Excretory System

Several in vivo studies targeted the beneficial effect of UD on the excretory system. Al-Akash et al. (2021), using an ethylene glycol-induced (EG) Urolithiatic rabbit model, reported that the deposition of oxalate, a contributing factor in the formation of stones within the urinary tract, was reduced upon UD supplementation [149]. Additionally, the infiltration of inflammatory cells into the kidney’s interstitial tissue, as a downstream consequence of urolithiasis, was also minimized in the treated group, further suggesting the role of UD in maintaining renal function following ethylene glycol poisoning. These findings are consistent with the conclusions of KELEŞ et al. (2020), who discovered that the supplementation of UD reversed the elevation of calcium, citrate, and oxalate levels in EG mice back to normal levels. Along these lines, UD revealed potent activity in reducing the accumulation of nitrogenous contaminants such as creatinine and uric acid in blood, which are usually increased during urinary obstruction [197]. Furthermore, in the kidney tissue of EG mice, glutathione levels were lower, and malondialdehyde levels were significantly higher compared to the control and UD groups, indicating oxidative stress and highlighting the antioxidant role of UD. Moreover, after a 4-week treatment with UD, Caspase-3 activity, which leads to apoptosis in renal cells of EG mice, was almost reversed, suggesting the inhibitory role of UD against programmed cell death in kidney stone formation. UD treatment also resulted in decreased levels of inflammatory biomarkers such as TNF-α and molecules involved in inflammatory pathways, including osteopontin and collagen, which play crucial roles in disease development. The UD group exhibited a significant decrease in KIM-1, a marker for tubulointerstitial damage, with kidney tissue damage approaching control values. In contrast, the EG group showed significant tissue damage and elevated levels of KIM-1 [197].
Furthermore, recent studies investigated the synergistic effect of a multicomponent nutraceutical formulation (NF) on the formation of Calcium oxalate and uric acid crystals in the renal tubular cell line HK2. The NF consisted of UD with agents considered stone inhibitors, namely Oreganum vulgare, Ceterach officinarum, Phyllanthus niruri, bromelain, potassium, and magnesium citrate. In comparison to the control group, NF showed a reduction effect in CaOx crystal formation. High uric acid blood levels, known as hyperuricemia, are closely associated with stone formation via the regulatory role of URAT1 and OAT1 regulatory transporters of urate in humans, recognized as key therapeutic targets for hyperuricemia. Interestingly, exposure to UD caused a significantly downregulated mRNA expression of both transporters, further highlighting its protective effects against kidney damage [198].

7.7. Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a common urological condition that affects men as they age, which can result in unpleasant urinary tract symptoms and can lead to functional urinary complications such as painful and excessive urination and recurrent urinary tract infections [199].
Alpha-blockers are currently effective treatments for BPH causing mild discomfort, resulting in a growing interest in medicinal herbs with fewer adverse effects. Indeed, UD can be used to treat urinary tract disorders related to BPH as no side effects have been reported [6,9,200,201,202]. The components of UD were described to interfere with multiple pathways involved in the development of BPH [90]. One of the most used clinical indexes in the assessment of BPH is the International Prostate Symptom Score (IPSS) [200], found to be significantly improved post-exposure to UD extract [203]. Similar results were reported by Men et al. (2016), correlating UD treatment with the improvement of quality of life among patients suffering from BPH [200,201,204]. However, there exist some inconsistencies in the literature with other studies reporting no significant amelioration of the IPSS score or clinical symptoms [200]. Karami et al. (2020) observed a weak effect of UD on the IPSS score and hypothesized that the lack of efficacy might be due to the short duration of the therapy [201]. Other studies completed the gaps by investigating other hallmarks such as the maximal urinary flow rate (Qmax), which was found to be increased along with a considerable decrease in the prostate volume upon exposure to UD [199]. Similarly, a study conducted by Sökeland (2020) confirmed a prominent increase in the Qmax of patients treated with UD. Even though there was no significant difference between the combination of UD with saw palmetto fruits and the 5-alpha reductase inhibitor, finasteride, treatment with UD was still recommended due to more favorable tolerability and safety compared with the drug [205,206]. The combination of UD with saw palmetto fruits exhibited a notable improvement in nocturnal voiding, similar to reference drugs tamsulosin and finasteride [207].
As mentioned above, the ability of UD to reduce the prostate volume might be responsible for the alleviation of BPH symptoms. In that regard, Safarinejad et al. observed a decrease in the prostatic volume when compared to the control group [200,202]. Finally, when compared to a placebo group, studies demonstrated that the postvoid residual urine (PVR) in UD-treated patients decreased, suggesting the therapeutic and beneficial activity of UD plant extract [203].
Moreover, investigations into the role of Sex Hormone-Binding Globulin (SHBG) shed further light on the mechanisms underlying the effects of UD on prostatic growth and function. Sex Hormone-Binding Globulin (SHBG) can bind to steroid hormones after adhering to prostatic stromal receptors in a ligand-free form [203]. This binding triggers an increase in intracellular cAMP production, activating protein kinase A and stimulating stromal proliferation [208]. Interestingly, lignans extracted from UD inhibited the binding of androgens to their transporter proteins SHBG, as well as the binding of these proteins to the membrane receptors of the prostate, halting their proliferative activity in prostate tissues [90,209]. Other studies further demonstrated that aqueous UD root extract effectively hindered the binding of SHBG with its receptor on male prostatic membrane surfaces [203].
As previously discussed, the antioxidant effect of UD may constitute a promising aspect of its therapeutic benefits. Indeed, collected data revealed a significant effect on oxidative and inflammatory proteins, mainly hs-CRP, MDA, and SOD, post-UD exposure [201]. The anti-inflammatory potential associated with this plant was further assessed using a combination of UD with Serenoa repens, which was able, through its antioxidant activity, to suppress the expression of proinflammatory pathways, including the NF-κB pathway, and to disrupt the progression of BPH. This leads to the inhibition of downstream cytokines, including IL-6 and IL-8, which have been associated with inflammation [203,210]. Congruent results were also reported for the combinations of UD with Curcuma Longa, Boswellia, Pinus pinaster, and soybean (Glycine max) [211].

8. Conclusions

Many researchers have explored medicinal plants for cancer treatment and prevention in recent years, particularly due to their high content in bioactive compounds, including vitamins and minerals along with a variety of secondary metabolites. Recent advances in basic research on the nettle plant have highlighted its potential use in the treatment of a wide range of diseases, including cancer. Although its potential benefits have yet to be fully defined, the existing literature has bolstered the pharmacological effects of UD both in vitro and in vivo. Several studies documented the antiproliferative, anti-inflammatory, antioxidant, analgesic, immunomodulator, and antimicrobial properties of UD along with its protective activity against hepatocellular, neurological, cardiovascular, excretory, and reproductive diseases. From the perspective of large-scale medical use, several human clinical investigations verified some of these pharmacological and nutritional benefits; however, more research is needed to confirm the perceived effects of UD and correlate its mechanism of action to its phytochemical constituents.

Author Contributions

Data curation and first draft preparation: M.A.S., M.Y., T.S., R.H., S.A.R., R.A.Y., L.D., J.L.D., F.F., R.I. and C.M. Project administration: M.A.S. and M.Y. Conceptualization: M.Y and S.R. Supervision and writing of the final draft: H.Y.N. and S.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We acknowledge financial support from the Open Access Publication Fund of the University of Veterinary Medicine Hannover Foundation.

Conflicts of Interest

The authors declare no conflict of interests.

Abbreviations

AMLAcute Myeloid Leukemia
ALLAcute Lymphocytic Leukemia
ADAAdenosine deaminase
AKTProtein Kinase B
BPHBenign Prostate Hyperplasia
CNSCentral Nervous System
EGEthylene Glycol
FSHFollicle Stimulating Hormone
GLUTGlucose Transporter Type
IGF1Insulin-like Growth Factor 1
IGF1RInsulin-like Growth Factor 1 Receptor
ILInterleukin
JAK2Janus Kinase 2
LHLuteinizing Hormone
LDLLow-Density Lipoprotein
HDFHuman Dermal Fibroblast
HDLHigh-Density Lipoprotein
HIVHuman Immunodeficiency Virus
hs-CRPHigh-Sensitivity C-Reactive Protein
MMPMatrix Metalloproteinases
NFNutraceutical Formulation
NFκBNuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells
NSCLCNon-Small Cell Lung Carcinoma
OAT 1Organic Anion Transporter 1
TNBCTriple-Negative Breast Cancer
PCOSPolycystic Ovaries Syndrome
PTENPhosphatase and TENsin Homolog
PI3KPhosphoinositide 3-Kinase
ROSReactive Oxygen Species
SHBGSex Hormone-Binding Globulin
URAT1Urate Transporter 1
VLDLVery-Low-Density Lipoprotein

References

  1. Schuhmacher, A.; Gassmann, O.; Hinder, M. Changing R&D Models in Research-Based Pharmaceutical Companies. J. Transl. Med. 2016, 14, 105. [Google Scholar] [CrossRef] [PubMed]
  2. Atanasov, A.G.; Waltenberger, B.; Pferschy-Wenzig, E.-M.; Linder, T.; Wawrosch, C.; Uhrin, P.; Temml, V.; Wang, L.; Schwaiger, S.; Heiss, E.H.; et al. Discovery and Resupply of Pharmacologically Active Plant-Derived Natural Products: A Review. Biotechnol. Adv. 2015, 33, 1582–1614. [Google Scholar] [CrossRef] [PubMed]
  3. Dhouibi, R.; Affes, H.; Ben Salem, M.; Hammami, S.; Sahnoun, Z.; Zeghal, K.M.; Ksouda, K. Screening of Pharmacological Uses of Urtica dioica and Others Benefits. Prog. Biophys. Mol. Biol. 2020, 150, 67–77. [Google Scholar] [CrossRef]
  4. Gupta, S.; Jain, R.; Kachhwaha, S.; Kothari, S.L. Nutritional and Medicinal Applications of Moringa oleifera Lam.—Review of Current Status and Future Possibilities. J. Herb. Med. 2018, 11, 1–11. [Google Scholar] [CrossRef]
  5. Kregiel, D.; Pawlikowska, E.; Antolak, H. Urtica spp.: Ordinary Plants with Extraordinary Properties. Molecules 2018, 23, 1664. [Google Scholar] [CrossRef] [PubMed]
  6. Ait Haj Said, A.; Otmani, I.S.E.; Derfoufi, S.; Benmoussa, A. Highlights on Nutritional and Therapeutic Value of Stinging Nettle (Urtica dioica). Int. J. Pharm. Pharm. Sci. 2015, 7, 8–14. [Google Scholar]
  7. Bhardwaj, D.; Giri, A.; Kumar, V.; Srivastava, V.C. Nettle (Urtica spp.) Phytotomy and Applications: Crop Variety Selection and Advanced Product Development for the Manufacturing of Natural Fiber Composites. Ind. Crops Prod. 2024, 210, 118180. [Google Scholar] [CrossRef]
  8. Paulauskienė, A.; Tarasevičienė, Ž.; Laukagalis, V. Influence of Harvesting Time on the Chemical Composition of Wild Stinging Nettle (Urtica dioica L.). Plants 2021, 10, 686. [Google Scholar] [CrossRef] [PubMed]
  9. Gürbüz, İ.; Özatkan, G.; Akaydin, G.; Günbatan, T. Ethnopharmacobotanical Findings of Medicinal Plants in the Kızılcahamam District of Ankara, Turkey. Turk. J. Pharm. Sci. 2021, 18, 667–682. [Google Scholar] [CrossRef] [PubMed]
  10. Jan, K.N.; Zarafshan, K.; Singh, S. Stinging Nettle (Urtica dioica L.): A Reservoir of Nutrition and Bioactive Components with Great Functional Potential. Food Meas. 2017, 11, 423–433. [Google Scholar] [CrossRef]
  11. Baumli, J.; Antal, N.; Casoni, D.; Cimpoiu, C. Use of Secondary Metabolites Profiling and Antioxidant Activity to Unravel the Differences between Two Species of Nettle. Plants 2023, 12, 3233. [Google Scholar] [CrossRef] [PubMed]
  12. Masłowski, M.; Aleksieiev, A.; Miedzianowska, J.; Efenberger-Szmechtyk, M.; Strzelec, K. Antioxidant and Anti–Aging Activity of Freeze–Dried Alcohol–Water Extracts from Common Nettle (Urtica dioica L.) and Peppermint (Mentha piperita L.) in Elastomer Vulcanizates. Polymers 2022, 14, 1460. [Google Scholar] [CrossRef] [PubMed]
  13. Moreira, S.A.; Silva, S.; Costa, E.M.; Saraiva, J.A.; Pintado, M. Effect of High Hydrostatic Pressure Extraction on Biological Activities of Stinging Nettle Extracts. Food Funct. 2020, 11, 921–931. [Google Scholar] [CrossRef] [PubMed]
  14. Trineeva, O.V.; Slivkin, A.I.; Safonova, E.F. Determination of Nettle Leaves Extracts Antioxidant Activity by Various Methods. Drug Dev. Regist. 2020, 9, 59–66. [Google Scholar] [CrossRef]
  15. Ligor, M.; Kiełbasa, A.; Ratiu, I.-A.; Buszewski, B. Separation and Quantification of Selected Sapogenins Extracted from Nettle, White Dead-Nettle, Common Soapwort and Washnut. Molecules 2021, 26, 7705. [Google Scholar] [CrossRef] [PubMed]
  16. Tarasevičienė, Ž.; Vitkauskaitė, M.; Paulauskienė, A.; Černiauskienė, J. Wild Stinging Nettle (Urtica dioica L.) Leaves and Roots Chemical Composition and Phenols Extraction. Plants 2023, 12, 309. [Google Scholar] [CrossRef] [PubMed]
  17. Panche, A.N.; Diwan, A.D.; Chandra, S.R. Flavonoids: An Overview. J. Nutr. Sci. 2016, 5, e47. [Google Scholar] [CrossRef]
  18. Kasouni, A.I.; Chatzimitakos, T.G.; Stalikas, C.D.; Trangas, T.; Papoudou-Bai, A.; Troganis, A.N. The Unexplored Wound Healing Activity of Urtica dioica L. Extract: An In Vitro and In Vivo Study. Molecules 2021, 26, 6248. [Google Scholar] [CrossRef] [PubMed]
  19. Đurović, S.; Kojić, I.; Radić, D.; Smyatskaya, Y.A.; Bazarnova, J.G.; Filip, S.; Tosti, T. Chemical Constituents of Stinging Nettle (Urtica dioica L.): A Comprehensive Review on Phenolic and Polyphenolic Compounds and Their Bioactivity. Int. J. Mol. Sci. 2024, 25, 3430. [Google Scholar] [CrossRef] [PubMed]
  20. Skalska-Kamińska, A.; Wójciak, W.; Żuk, M.; Paduch, R.; Wójciak, M. Protective Effect of Urtica dioica Extract against Oxidative Stress in Human Skin Fibroblasts. Life 2023, 13, 2182. [Google Scholar] [CrossRef]
  21. Repajić, M.; Cegledi, E.; Zorić, Z.; Pedisić, S.; Elez Garofulić, I.; Radman, S.; Palčić, I.; Dragović-Uzelac, V. Bioactive Compounds in Wild Nettle (Urtica dioica L.) Leaves and Stalks: Polyphenols and Pigments upon Seasonal and Habitat Variations. Foods 2021, 10, 190. [Google Scholar] [CrossRef] [PubMed]
  22. Jeszka-Skowron, M.; Zgoła-Grześkowiak, A.; Frankowski, R.; Grześkowiak, T.; Jeszka, A.M. Variation in the Content of Bioactive Compounds in Infusions Prepared from Different Parts of Wild Polish Stinging Nettle (Urtica dioica L.). Molecules 2022, 27, 4242. [Google Scholar] [CrossRef]
  23. Devkota, H.P.; Paudel, K.R.; Khanal, S.; Baral, A.; Panth, N.; Adhikari-Devkota, A.; Jha, N.K.; Das, N.; Singh, S.K.; Chellappan, D.K.; et al. Stinging Nettle (Urtica dioica L.): Nutritional Composition, Bioactive Compounds, and Food Functional Properties. Molecules 2022, 27, 5219. [Google Scholar] [CrossRef]
  24. Samadian, E.; Colagar, A.H.; Safarzad, M.; Asadi, J.; Mansouri, K. Inhibitory Potency of the Nettle Lectin on Neovascularization: A Biomolecule for Carbohydrate-Mediated Targeting of Angiogenesis. Mol. Biol. Rep. 2023, 50, 4491–4503. [Google Scholar] [CrossRef] [PubMed]
  25. Jafari, Z.; Samani, S.A.; Jafari, M. Insights into the Bioactive Compounds and Physico-Chemical Characteristics of the Extracted Oils from Urtica dioica and Urtica Pilulifera. SN Appl. Sci. 2020, 2, 416. [Google Scholar] [CrossRef]
  26. Mitrović, J.; Nikolić, N.; Ristić, I.; Karabegović, I.; Savić, S.; Šimurina, O.; Cvetković, B.; Pešić, M. The Chemical Characterisation of Nettle (Urtica dioica L.) Seed Oil. Nat. Prod. Res. 2023. ahead of print. [Google Scholar]
  27. Marchut-Mikołajczyk, O.; Chlebicz, M.; Kawecka, M.; Michalak, A.; Prucnal, F.; Nielipinski, M.; Filipek, J.; Jankowska, M.; Perek, Z.; Drożdżyński, P.; et al. Endophytic Bacteria Isolated from Urtica dioica L.—Preliminary Screening for Enzyme and Polyphenols Production. Microb. Cell Factories 2023, 22, 169. [Google Scholar] [CrossRef] [PubMed]
  28. Đurović, S.; Šorgić, S.; Popov, S.; Pezo, L.; Mašković, P.; Blagojević, S.; Zeković, Z. Recovery of Biologically Active Compounds from Stinging Nettle Leaves Part I: Supercritical Carbon Dioxide Extraction. Food Chem. 2022, 373, 131724. [Google Scholar] [CrossRef]
  29. Karg, C.A.; Doppler, C.; Schilling, C.; Jakobs, F.; Dal Colle, M.C.S.; Frey, N.; Bernhard, D.; Vollmar, A.M.; Moser, S. A Yellow Chlorophyll Catabolite in Leaves of Urtica dioica L.: An Overlooked Phytochemical That Contributes to Health Benefits of Stinging Nettle. Food Chem. 2021, 359, 129906. [Google Scholar] [CrossRef] [PubMed]
  30. Adhikari, B.M.; Bajracharya, A.; Shrestha, A.K. Comparison of Nutritional Properties of Stinging Nettle (Urtica dioica) Flour with Wheat and Barley Flours. Food Sci. Nutr. 2015, 4, 119–124. [Google Scholar] [CrossRef]
  31. Bhusal, K.K.; Magar, S.K.; Thapa, R.; Lamsal, A.; Bhandari, S.; Maharjan, R.; Shrestha, S.; Shrestha, J. Nutritional and Pharmacological Importance of Stinging Nettle (Urtica dioica L.): A Review. Heliyon 2022, 8, e09717. [Google Scholar] [CrossRef] [PubMed]
  32. Koczkodaj, S.; Przybył, J.L.; Kosakowska, O.; Węglarz, Z.; Bączek, K.B. Intraspecific Variability of Stinging Nettle (Urtica dioica L.). Molecules 2023, 28, 1505. [Google Scholar] [CrossRef]
  33. Behboodi, H.; Alemi, M.; Baradaran, A. Urtica dioica Extract—Suitable Dietary Supplement Influencing the Growth Body Characteristics, Antioxidant Status, and Serum Biochemical Parameters of Broiler Chickens. Comp. Clin. Pathol. 2021, 30, 913–920. [Google Scholar] [CrossRef]
  34. Mirsaiidi Farahani, M.; Hosseinian, S.A. Effects of Dietary Stinging Nettle (Urtica dioica) on Hormone Stress and Selected Serum Biochemical Parameters of Broilers Subjected to Chronic Heat Stress. Vet. Med. Sci. 2022, 8, 660–667. [Google Scholar] [CrossRef] [PubMed]
  35. Nallan Chakravartula, S.S.; Moscetti, R.; Farinon, B.; Vinciguerra, V.; Merendino, N.; Bedini, G.; Neri, L.; Pittia, P.; Massantini, R. Stinging Nettles as Potential Food Additive: Effect of Drying Processes on Quality Characteristics of Leaf Powders. Foods 2021, 10, 1152. [Google Scholar] [CrossRef]
  36. Zhang, Y.; Zhang, X.; Zafar, M.H.; Zhang, J.; Wang, J.; Yu, X.; Liu, W.; Wang, M. Research Progress in Physiological Effects of Resistant Substances of Urtica dioica L. on Animal Performance and Feed Conversion. Front. Plant Sci. 2023, 14, 1164363. [Google Scholar] [CrossRef] [PubMed]
  37. Alibas, I. Energy Consumption and Colour Characteristics of Nettle Leaves during Microwave, Vacuum and Convective Drying. Biosyst. Eng. 2007, 96, 495–502. [Google Scholar] [CrossRef]
  38. Lule, F.; Koyuncu, T. Convective and Microwave Drying Characteristics, Energy Requirementand Color Retention of Dehydrated Nettle Leaves (Urtica diocia L.). Legume Res. 2017, 40, 649–654. [Google Scholar]
  39. Asgarpanah, J.; Mohajerani, R. Phytochemistry and Pharmacologic Properties of Urtica dioica L. J. Med. Plants Res. 2012, 6, 5714–5719. [Google Scholar]
  40. Firoozi, M.; Barari, A.; Abbassi Daloii, A.; Abednatanzi, H. The Effect of Interval Training and Urtica dioica Hydroalcoholic Extract on Some Growth and Immune Factors in C57 Rats with Melanoma Cancer. Complement. Med. J. 2024, 13, 44–53. [Google Scholar] [CrossRef]
  41. Motamedi, H.; Seyyednejad, S.M.; Bakhtiari, A.; Vafaei, M. Introducing Urtica dioica, A Native Plant of Khuzestan, As an Antibacterial Medicinal Plant. Jundishapur. J. Nat. Pharm. Prod. 2014, 9, e15904. [Google Scholar] [CrossRef] [PubMed]
  42. Marotti, I.; Frassineti, E.; Trebbi, G.; Alpi, M.; D’Amen, E.; Dinelli, G. Health-Promoting Phytochemicals of Stinging Nettle (Urtica dioica L). Grown under Organic Farming in Italian Environments. Ind. Crops Prod. 2022, 182, 114903. [Google Scholar] [CrossRef]
  43. Kőszegi, K.; Békássy-Molnár, E.; Koczka, N.; Kerner, T.; Stefanovits-Bányai, É. Changes in Total Polyphenol Content and Antioxidant Capacity of Stinging Nettle (Urtica dioica L.) from Spring to Autumn. Period. Polytech. Chem. Eng. 2020, 64, 548–554. [Google Scholar] [CrossRef]
  44. Uğur, Y.; Güzel, A. Determination of Phytochemical Content by LC-MS/MS, Investigation of Antioxidant Capacity, and Enzyme Inhibition Effects of Nettle (Urtica dioica). Eur. Rev. Med. Pharmacol. Sci. 2023, 27, 1793–1800. [Google Scholar] [CrossRef] [PubMed]
  45. Chehri, A.; Yarani, R.; Yousefi, Z.; Novin Bahador, T.; Shakouri, S.K.; Ostadrahimi, A.; Mobasseri, M.; Pociot, F.; Araj-Khodaei, M. Anti-Diabetic Potential of Urtica dioica: Current Knowledge and Future Direction. J. Diabetes Metab. Disord. 2022, 21, 931–940. [Google Scholar] [CrossRef] [PubMed]
  46. Jaiswal, V.; Lee, H.-J. Antioxidant Activity of Urtica dioica: An Important Property Contributing to Multiple Biological Activities. Antioxidants 2022, 11, 2494. [Google Scholar] [CrossRef] [PubMed]
  47. Semwal, P.; Rauf, A.; Olatunde, A.; Singh, P.; Zaky, M.Y.; Islam, M.M.; Khalil, A.A.; Aljohani, A.S.M.; Al Abdulmonem, W.; Ribaudo, G. The Medicinal Chemistry of Urtica dioica L.: From Preliminary Evidence to Clinical Studies Supporting Its Neuroprotective Activity. Nat. Prod. Bioprospect. 2023, 13, 16. [Google Scholar] [CrossRef]
  48. Esposito, S.; Bianco, A.; Russo, R.; Di Maro, A.; Isernia, C.; Pedone, P.V. Therapeutic Perspectives of Molecules from Urtica dioica Extracts for Cancer Treatment. Molecules 2019, 24, 2753. [Google Scholar] [CrossRef] [PubMed]
  49. Zhang, W.; Cao, G.; Wu, F.; Wang, Y.; Liu, Z.; Hu, H.; Xu, K. Global Burden of Prostate Cancer and Association with Socioeconomic Status, 1990–2019: A Systematic Analysis from the Global Burden of Disease Study. J. Epidemiol. Glob. Health 2023, 13, 407–421. [Google Scholar] [CrossRef] [PubMed]
  50. Mohammadi, A.; Mansoori, B.; Aghapour, M.; Baradaran, B. Urtica dioica Dichloromethane Extract Induce Apoptosis from Intrinsic Pathway on Human Prostate Cancer Cells (PC3). Cell. Mol. Biol. 2016, 62, 78–83. [Google Scholar] [PubMed]
  51. Levy, A.; Sivanesan, D.; Murugan, R.; Jornadal, J.; Quinonez, Y.; Jaffe, M.; Rathinavelu, A. Urtica dioica Induces Cytotoxicity in Human Prostate Carcinoma LNCaP Cells: Involvement of Oxidative Stress, Mitochondrial Depolarization and Apoptosis. Trop. J. Pharm. Res. 2014, 13, 711–717. [Google Scholar] [CrossRef]
  52. Konrad, L.; Müller, H.-H.; Lenz, C.; Laubinger, H.; Aumüller, G.; Lichius, J.J. Antiproliferative Effect on Human Prostate Cancer Cells by a Stinging Nettle Root (Urtica dioica) Extract. Planta Med. 2000, 66, 44–47. [Google Scholar] [CrossRef]
  53. Tekin, V.; Kozgus Guldu, O.; Medine, E.I.; Biber Muftuler, F.Z. Examination of the Association Between 3,4-Divanillyltetrahydrofuran Lignan (Urtica dioica Origin) and Prostate Cancer Cells by 131I Radiolabeling. Cancer Biother. Radiopharm. 2021, 36, 326–332. [Google Scholar] [CrossRef] [PubMed]
  54. Brusselmans, K.; Vrolix, R.; Verhoeven, G.; Swinnen, J.V. Induction of Cancer Cell Apoptosis by Flavonoids Is Associated with Their Ability to Inhibit Fatty Acid Synthase Activity *. J. Biol. Chem. 2005, 280, 5636–5645. [Google Scholar] [CrossRef] [PubMed]
  55. Jan, R.; Chaudhry, G.-S. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics. Adv. Pharm. Bull. 2019, 9, 205–218. [Google Scholar] [CrossRef] [PubMed]
  56. Horvitz, H.R. Worms, Life, and Death (Nobel Lecture). ChemBioChem 2003, 4, 697–711. [Google Scholar] [CrossRef] [PubMed]
  57. Güler, E. Investigaton of Chemopreventive Properties of Urtica dioica L., in MCF-7 and MDA231 Breast Cancer Cell Lines. Ph.D.—Doctoral Program, Middle East Technical University, Ankara, Turkey, 2011. [Google Scholar]
  58. Simon, H.-U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of Reactive Oxygen Species (ROS) in Apoptosis Induction. Apoptosis 2000, 5, 415–418. [Google Scholar] [CrossRef] [PubMed]
  59. Durak, I.; Biri, H.; Devrim, E.; Sözen, S.; Avcı, A. Aqueous Extract of Urtica dioica Makes Significant Inhibition on Adenosine Deaminase Activity in Prostate Tissue from Patients with Prostate Cancer. Cancer Biol. Ther. 2004, 3, 855–857. [Google Scholar] [CrossRef] [PubMed]
  60. Fattahi, S.; Ardekani, A.M.; Zabihi, E.; Abedian, Z.; Mostafazadeh, A.; Pourbagher, R.; Akhavan-Niaki, H. Antioxidant and Apoptotic Effects of an Aqueous Extract of Urtica dioica on the MCF-7 Human Breast Cancer Cell Line. Asian Pac. J. Cancer Prev. 2013, 14, 5317–5323. [Google Scholar] [CrossRef]
  61. Apak, R.; Güçlü, K.; Demirata, B.; Özyürek, M.; Çelik, S.E.; Bektaşoğlu, B.; Berker, K.I.; Özyurt, D. Comparative Evaluation of Various Total Antioxidant Capacity Assays Applied to Phenolic Compounds with the CUPRAC Assay. Molecules 2007, 12, 1496–1547. [Google Scholar] [CrossRef]
  62. Fattahi, S.; Ghadami, E.; Asouri, M.; Ardekanid, A.M.; Akhavan-Niaki, H. Urtica dioica Inhibits Cell Growth and Induces Apoptosis by Targeting Ornithine Decarboxylase and Adenosine Deaminase as Key Regulatory Enzymes in Adenosine and Polyamines Homeostasis in Human Breast Cancer Cell Lines. Cell. Mol. Biol. 2018, 64, 97–102. [Google Scholar] [CrossRef] [PubMed]
  63. Wenyuan, J.I.; Shaoyin, W.E.I.; Wei, L.I.U. Effects of Urtica dioica extract on malignant biological behaviors of breast cancer cells and its possible mechanism. Chin. J. Cancer Biother. 2021, 28, 803–809. [Google Scholar]
  64. Karakol, P.; Saraydin, S.U.; Bozkurt, M.; Hepokur, C.; Inan, Z.D.S.; Turan, M. Anticancer Effects of Urtica dioica in Breast Cancer. Asian Pac. J. Cancer Prev. 2022, 23, 673–681. [Google Scholar] [CrossRef]
  65. Upreti, S.; Muduli, K.; Pradhan, J.; Elangovan, S.; Samant, M. Identification of Novel Inhibitors from Urtica Spp against TNBC Targeting JAK2 Receptor for Breast Cancer Therapy. Med. Oncol. 2023, 40, 326. [Google Scholar] [CrossRef]
  66. Mansoori, B.; Mohammadi, A.; Hashemzadeh, S.; Shirjang, S.; Baradaran, A.; Asadi, M.; Doustvandi, M.A.; Baradaran, B. Urtica dioica Extract Suppresses miR-21 and Metastasis-Related Genes in Breast Cancer. Biomed. Pharmacother. 2017, 93, 95–102. [Google Scholar] [CrossRef] [PubMed]
  67. Mohammadi, A.; Mansoori, B.; Aghapour, M.; Shirjang, S.; Nami, S.; Baradaran, B. The Urtica dioica Extract Enhances Sensitivity of Paclitaxel Drug to MDA-MB-468 Breast Cancer Cells. Biomed. Pharmacother. 2016, 83, 835–842. [Google Scholar] [CrossRef] [PubMed]
  68. Nafeh, G.; Abi Akl, M.; Samarani, J.; Bahous, R.; Al Kari, G.; Younes, M.; Sarkis, R.; Rizk, S. Urtica dioica Leaf Infusion Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Cisplatin Treatment. Pharmaceuticals 2023, 16, 780. [Google Scholar] [CrossRef]
  69. Hashem, A.H.; Salem, S.S. Green and Ecofriendly Biosynthesis of Selenium Nanoparticles Using Urtica dioica (Stinging Nettle) Leaf Extract: Antimicrobial and Anticancer Activity. Biotechnol. J. 2021, 17, 2100432. [Google Scholar] [CrossRef] [PubMed]
  70. Dağlıoğlu, Y.; Öztürk, B.Y.; Khatami, M. Apoptotic, Cytotoxic, Antioxidant, and Antibacterial Activities of Biosynthesized Silver Nanoparticles from Nettle Leaf. Microsc. Res. Tech. 2023, 86, 669–685. [Google Scholar] [CrossRef]
  71. Telo, S.; Halifeoglu, I.; Ozercan, I.H. Effects of Stinging Nettle (Urtica dioica L.) on Antioxidant Enzyme Activities in Rat Model of Mammary Gland Cancer. Iran. J. Pharm. Res. 2017, 16, 164–170. [Google Scholar] [PubMed]
  72. Mohammadi, A.; Mansoori, B.; Baradaran, P.C.; Khaze, V.; Aghapour, M.; Farhadi, M.; Baradaran, B. Urtica dioica Extract Inhibits Proliferation and Induces Apoptosis and Related Gene Expression of Breast Cancer Cells In Vitro and In Vivo. Clin. Breast Cancer 2017, 17, 463–470. [Google Scholar] [CrossRef] [PubMed]
  73. Dong, Y.; Shi, O.; Zeng, Q.; Lu, X.; Wang, W.; Li, Y.; Wang, Q. Leukemia Incidence Trends at the Global, Regional, and National Level between 1990 and 2017. Exp. Hematol. Oncol. 2020, 9, 14. [Google Scholar] [CrossRef] [PubMed]
  74. Temïz, E.; Koyuncu, İ.; Dds, K.A.S.M.S.; Yüksekdağ, Ö.; Award, Y. Exploring the Antiproliferative Mechanisms of Urtica dioica L. Extract in Human Promyelocytic Leukemia Cell Line: İnsan Promiyelositik Lösemi Hücre Hattında Isırgan Ekstraktının Antiproliferatif Mekanizmalarının Araştırılması. J. Harran Univ. Med. Fac./Harran Üniversitesi Tıp Fakültesi Derg. 2021, 18, 468–474. [Google Scholar] [CrossRef]
  75. Hodroj, M.H.; Al Bast, N.a.H.; Taleb, R.I.; Borjac, J.; Rizk, S. Nettle Tea Inhibits Growth of Acute Myeloid Leukemia Cells In Vitro by Promoting Apoptosis. Nutrients 2020, 12, 2629. [Google Scholar] [CrossRef] [PubMed]
  76. Keshavarz, S.; Ardekani, M.R.S.; Safavi, M.; Chahardouli, B.; Nadali, F. In Vitro Cytotoxic Effect of Urtica dioica Extracts on Acute Myelogenous Leukemia Cell Line (Kg-1). Arch. Med. Lab. Sci. 2016, 2, 12–18. [Google Scholar] [CrossRef]
  77. Rashidbaghan, A.; Mostafaie, A.; Yazdani, Y.; Mansouri, K. Urtica dioica Agglutinin (a Plant Lectin) Has a Caspase-Dependent Apoptosis Induction Effect on the Acute Lymphoblastic Leukemia Cell Line. Cell. Mol. Biol. 2020, 66, 121–126. [Google Scholar] [CrossRef] [PubMed]
  78. Rashidbaghan, A.; Mostafaie, A.; Yazdani, Y.; Mansouri, K. The Agglutinin of Common Nettle (Urtica dioica L.) Plant Effects on Gene Expression Related to Apoptosis of Human Acute Myeloid Leukemia Cell Line. Biochem. Genet. 2021, 59, 1049–1064. [Google Scholar] [CrossRef] [PubMed]
  79. Kawabata, Y.; Hirokawa, M.; Kitabayashi, A.; Horiuchi, T.; Kuroki, J.; Miura, A.B. Defective Apoptotic Signal Transduction Pathway Downstream of Caspase-3 in Human B-Lymphoma Cells: A Novel Mechanism of Nuclear Apoptosis Resistance. Blood 1999, 94, 3523–3530. [Google Scholar] [CrossRef] [PubMed]
  80. Luciano, F.; Ricci, J.E.; Herrant, M.; Bertolotto, C.; Mari, B.; Cousin, J.L.; Auberger, P. T and B Leukemic Cell Lines Exhibit Different Requirements for Cell Death: Correlation between Caspase Activation, DFF40/DFF45 Expression, DNA Fragmentation and Apoptosis in T Cell Lines but Not in Burkitt’s Lymphoma. Leukemia 2002, 16, 700–707. [Google Scholar] [CrossRef] [PubMed]
  81. Mohammadi, A.; Mansoori, B.; Aghapour, M.; Baradaran, P.C.; Shajari, N.; Davudian, S.; Salehi, S.; Baradaran, B. The Herbal Medicine Utrica Dioica Inhibits Proliferation of Colorectal Cancer Cell Line by Inducing Apoptosis and Arrest at the G2/M Phase. J. Gastrointest. Cancer 2016, 47, 187–195. [Google Scholar] [CrossRef] [PubMed]
  82. Nieves, M.-A.; Navas-Carrillo, D.; Esteban, O.-P. Medicinal Plants: Active Compounds, Properties and Antiproliferative Effects in Colorectal Cancer. Phytochem. Rev. 2020, 19, 123–137. [Google Scholar] [CrossRef]
  83. Kardan, M.; Rafiei, A.; Golpour, M.; Ebrahimzadeh, M.A.; Akhavan-Niaki, H.; Fattahi, S. Urtica dioica Extract Inhibits Cell Proliferation and Induces Apoptosis in HepG2 and HTC116 as Gastrointestinal Cancer Cell Lines. Anti-Cancer Agents Med. Chem. 2020, 20, 963–969. [Google Scholar] [CrossRef] [PubMed]
  84. Ozben, T. Oxidative Stress and Apoptosis: Impact on Cancer Therapy. J. Pharm. Sci. 2007, 96, 2181–2196. [Google Scholar] [CrossRef] [PubMed]
  85. Matés, J.M.; Segura, J.A.; Alonso, F.J.; Márquez, J. Oxidative Stress in Apoptosis and Cancer: An Update. Arch. Toxicol. 2012, 86, 1649–1665. [Google Scholar] [CrossRef] [PubMed]
  86. Ghasemi, S.; Moradzadeh, M.; Mousavi, S.H.; Sadeghnia, H.R. Cytotoxic Effects of Urtica dioica Radix on Human Colon (HT29) and Gastric (MKN45) Cancer Cells Mediated through Oxidative and Apoptotic Mechanisms. Cell. Mol. Biol. 2016, 62, 90–96. [Google Scholar] [PubMed]
  87. Su, L.-J.; Zhang, J.-H.; Gomez, H.; Murugan, R.; Hong, X.; Xu, D.; Jiang, F.; Peng, Z.-Y. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxidative Med. Cell. Longev. 2019, 2019, 5080843. [Google Scholar] [CrossRef]
  88. Uyar, A.; Doğan, A.; Yaman, T.; Keleş, Ö.F.; Yener, Z.; Çelik, İ.; Alkan, E.E. The Protective Role of Urtica dioica Seed Extract Against Azoxymethane-Induced Colon Carcinogenesis in Rats. Nutr. Cancer 2022, 74, 306–319. [Google Scholar] [CrossRef] [PubMed]
  89. Rahmani, Z.; Karimi, M.; Saffari, I.; Mirzaei, H.; Nejati, M.; Sharafati Chaleshtori, R. Nanoemulsion and Nanoencapsulation of a Hydroethanolic Extract of Nettle (Urtica dioica) and Wormwood (Artemisia absinthium): Comparison of Antibacterial and Anticancer Activity. Front. Chem. 2024, 12, 1266573. [Google Scholar] [CrossRef] [PubMed]
  90. Chrubasik, J.E.; Roufogalis, B.D.; Wagner, H.; Chrubasik, S. A Comprehensive Review on the Stinging Nettle Effect and Efficacy Profiles. Part II: Urticae Radix. Phytomedicine 2007, 14, 568–579. [Google Scholar] [CrossRef] [PubMed]
  91. Ahmed, A.A.; Kamal, D.Y.M.; Abdulla, D.B.H. Study the Apoptotic Effect of N_butanol Extract of Urtica dioica on T24 Bladder Cancer Cell Line. Syst. Rev. Pharm. 2020, 11, 1005–1012. [Google Scholar] [CrossRef]
  92. D’Abrosca, B.; Ciaramella, V.; Graziani, V.; Papaccio, F.; Della Corte, C.M.; Potenza, N.; Fiorentino, A.; Ciardiello, F.; Morgillo, F. Urtica dioica L. Inhibits Proliferation and Enhances Cisplatin Cytotoxicity in NSCLC Cells via Endoplasmic Reticulum-Stress Mediated Apoptosis. Sci. Rep. 2019, 9, 4986. [Google Scholar] [CrossRef]
  93. Ramachandran, A. Know the Signs and Symptoms of Diabetes. Indian J. Med. Res. 2014, 140, 579–581. [Google Scholar] [PubMed]
  94. Qujeq, D. Effect of Urtica dioica Leaf Extract on Activities of Nucleoside Diphosphate Kinase and Acetyl Coenzyme, a Carboxylase, in Normal and Hyperglycemic Rats. Afr. J. Pharm. Pharmacol. 2011, 5, 792–796. [Google Scholar] [CrossRef]
  95. Rokeya, B. Antihyperglycemic and Antihyperlipidemic Activity of Urtica dioica on Type 2 Diabetic Model Rats. Diabetology 2011, 2, 1–6. [Google Scholar]
  96. Patel, D.; Prasad, S.; Kumar, R.; Hemalatha, S. An Overview on Antidiabetic Medicinal Plants Having Insulin Mimetic Property. Asian Pac. J. Trop. Biomed. 2012, 2, 320–330. [Google Scholar] [CrossRef]
  97. Patel, S.S.; Udayabanu, M. Urtica dioica Extract Attenuates Depressive like Behavior and Associative Memory Dysfunction in Dexamethasone Induced Diabetic Mice. Metab. Brain Dis. 2014, 29, 121–130. [Google Scholar] [CrossRef] [PubMed]
  98. Farzami, B.; Ahmadvand, D.; Vardasbi, S.; Majin, J.; Khaghani, S. Induction of Insulin Secretion by a Component of Urtica dioica Leave Extract in Perifused Islets of Langerhans and Its in vivo Effects in Normal and Streptozotocin Diabetic Rats. J. Ethnopharmacol. 2003, 89, 47–53. [Google Scholar] [CrossRef] [PubMed]
  99. Rahmati, M.; Keshvari, M.; Mirnasouri, R.; Chehelcheraghi, F. Exercise and Urtica dioica Extract Ameliorate Hippocampal Insulin Signaling, Oxidative Stress, Neuroinflammation, and Cognitive Function in STZ-Induced Diabetic Rats. Biomed. Pharmacother. 2021, 139, 111577. [Google Scholar] [CrossRef]
  100. Zamani-Garmsiri, F.; Akmali, M.; Gohari, A.; Zal, F.; Seghatoleslam, A. Urtica dioica (Gazaneh) Distillate Restores Glucose Metabolism in Diabetic Rats. Int. J. Prev. Med. 2023, 14, 68. [Google Scholar] [CrossRef]
  101. Golalipour, M.J.; Ghafari, S.; Kouri, V.; Kestkar, A.A. Proliferation of the b-Cells of Pancreas in Diabetic Rats Treated with Urtica dioica. Int. J. Morphol. 2010, 28, 399–404. [Google Scholar] [CrossRef]
  102. Qujeq, D.; Tatar, M.; Feizi, F.; Parsian, H.; Sohan Faraji, A.; Halalkhor, S. Effect of Urtica dioica Leaf Alcoholic and Aqueous Extracts on the Number and the Diameter of the Islets in Diabetic Rats. Int. J. Mol. Cell Med. 2013, 2, 21–26. [Google Scholar] [PubMed]
  103. Pérez Gutiérrez, R.M.; Muñiz-Ramirez, A.; Garcia-Campoy, A.H.; Mota Flores, J.M. Evaluation of the Antidiabetic Potential of Extracts of Urtica dioica, Apium Graveolens, and Zingiber Officinale in Mice, Zebrafish, and Pancreatic β-Cell. Plants 2021, 10, 1438. [Google Scholar] [CrossRef] [PubMed]
  104. Mehrizi, R.K.; Mozaffari-Khosravi, H.; Aboee, P. The Effect of Urtica dioica Extract on Blood Lipids Profile in Patients with Type 2 Diabetes: A Randomized Double-Blinded Clinical Trial. J. Nutr. Food Secur. 2020, 6, 315–320. [Google Scholar] [CrossRef]
  105. Fan, S.; Raychaudhuri, S.; Kraus, O.; Shahinozzaman, M.; Lofti, L.; Obanda, D.N. Urtica dioica Whole Vegetable as a Functional Food Targeting Fat Accumulation and Insulin Resistance-a Preliminary Study in a Mouse Pre-Diabetic Model. Nutrients 2020, 12, 1059. [Google Scholar] [CrossRef] [PubMed]
  106. Seyydi, S.M.; Tofighi, A.; Rahmati, M.; Tolouei Azar, J. Exercise and Urtica dioica Extract Ameliorate Mitochondrial Function and the Expression of Cardiac Muscle Nuclear Respiratory Factor 2 and Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha in STZ-Induced Diabetic Rats. Gene 2022, 822, 146351. [Google Scholar] [CrossRef]
  107. Sharma, S.; Padhi, S.; Chourasia, R.; Dey, S.; Patnaik, S.; Sahoo, D. Phytoconstituents from Urtica dioica (Stinging Nettle) of Sikkim Himalaya and Their Molecular Docking Interactions Revealed Their Nutraceutical Potential as α-Amylase and α-Glucosidase Inhibitors. J. Food Sci. Technol. 2023, 60, 2649–2658. [Google Scholar] [CrossRef] [PubMed]
  108. Altamimi, M.A.; Abu-Reidah, I.M.; Altamimi, A.; Jaradat, N. Hydroethanolic Extract of Urtica dioica L. (Stinging Nettle) Leaves as Disaccharidase Inhibitor and Glucose Transport in Caco-2 Hinderer. Molecules 2022, 27, 8872. [Google Scholar] [CrossRef] [PubMed]
  109. Rahimzadeh, M.; Jahanshahi, S.; Moein, S.; Moein, M.R. Evaluation of Alpha- Amylase Inhibition by Urtica dioica and Juglans Regia Extracts. Iran. J. Basic Med. Sci. 2014, 17, 465–469. [Google Scholar] [PubMed]
  110. van Gerwen, J.; Shun-Shion, A.S.; Fazakerley, D.J. Insulin Signalling and GLUT4 Trafficking in Insulin Resistance. Biochem. Soc. Trans. 2023, 51, 1057–1069. [Google Scholar] [CrossRef]
  111. Tabrizi, R.; Sekhavati, E.; Nowrouzi-Sohrabi, P.; Rezaei, S.; Tabari, P.; Ghoran, S.H.; Jamali, N.; Jalali, M.; Moosavi, M.; Kolahi, A.-A.; et al. Effects of Urtica dioica on Metabolic Profiles in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Clinical Trials. Mini-Rev. Med. Chem. 2022, 22, 550–563. [Google Scholar] [PubMed]
  112. Kianbakht, S.; Khalighi-Sigaroodi, F.; Dabaghian, F.H. Improved Glycemic Control in Patients with Advanced Type 2 Diabetes Mellitus Taking Urtica dioica Leaf Extract: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Clin. Lab. 2013, 59, 1071–1076. [Google Scholar] [CrossRef] [PubMed]
  113. Shahrokhi, M.; Koohmanaee, S.; Haghghi, R.; Rad, A.H.; Esfandiari, M.A.; Parvinroo, S.; Dalili, S. Urtica dioica (Nettle) in Type 1 Diabetes Mellitus: A Randomized Controlled Trial. Iran. J. Pediatr. 2023, 33, e137563. [Google Scholar] [CrossRef]
  114. Riazi, G.H.; Razzaghy-Azar, M.; Taghikhani, M.; Karimai, M.; Shaabani, M.; Komeleh, S.H.H.; Yousefi, M. Metabolic Effects of Glucose Lowering Substance of Urtica dioica on Normal and Diabetic Mice, and Patients with Type I Diabetes Mellitus. J. Compr. Ped. 2007, 1, e93732. [Google Scholar]
  115. Ali, H.; Hussain, S.; Taaban, S.; Abdul, I.; Khalaf, H.; Hamad, M.; Chaiad, J. Evaluation of the Inhibition Activity of Alcoholic Extracts of Urtica dioica, Sylibium marianum and Origanum vulgare Plants against Some Pathogenic Microorganisms Related with Food Diseases. Ann. Agri Bio Res. 2021, 26, 138–144. [Google Scholar]
  116. Du, J.; Fu, J.; Chen, T. Investigation of the Antibacterial Properties and Mode of Action of Compounds from Urtica dioica L. Cureus 2024, 16, e52083. [Google Scholar] [CrossRef]
  117. Pournajafian, A.; Naseri, A.; Fata, A.; Rakhshandeh, H.; Aghaee, M.A. The Antifungal Effects of Hydroalcoholic Extracts of Nigella Sativa and Urtica dioica on Fungal Agents in Comparison with Amphotericin B. J. Isfahan Med. Sch. 2021, 39, 198–205. [Google Scholar]
  118. Sabzian-Molaei, F.; Hosseini, S.; Alipour, A.; Ghaderi, H.; Fotouhi-Chahouki, F.; Hadi, A.; Shahsavarani, H. Urtica dioica Agglutinin (UDA) as a Potential Candidate for Inhibition of SARS-CoV-2 Omicron Variants: In Silico Prediction and Experimental Validation. Phytomedicine 2023, 111, 154648. [Google Scholar] [CrossRef]
  119. Modarresi-Chahardehi, A.; Ibrahim, D.; Fariza-Sulaiman, S.; Mousavi, L. Screening antimicrobial activity of various extracts of Urtica dioica. Rev. Biol. Trop. 2012, 60, 1567–1576. [Google Scholar] [CrossRef] [PubMed]
  120. Salehzadeh, A.; Asadpour, L.; Naeemi, A.S.; Houshmand, E. Antimicrobial Activity of Methanolic Extracts of Sambucus Ebulus and Urtica dioica Against Clinical Isolates of Methicillin Resistant Staphylococcus aureus. Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 38–40. [Google Scholar] [CrossRef] [PubMed]
  121. Choodari Gharehpapagh, A.; Farahpour, M.R.; Jafarirad, S. The Biological Synthesis of Gold/Perlite Nanocomposite Using Urtica dioica Extract and Its Chitosan-Capped Derivative for Healing Wounds Infected with Methicillin-Resistant Staphylococcus aureus. Int. J. Biol. Macromol. 2021, 183, 447–456. [Google Scholar] [CrossRef] [PubMed]
  122. Ghiyasi, Y.; Salahi, E.; Esfahani, H. Synergy Effect of Urtica dioica and ZnO NPs on Microstructure, Antibacterial Activity and Cytotoxicity of Electrospun PCL Scaffold for Wound Dressing Application. Mater. Today Commun. 2021, 26, 102163. [Google Scholar] [CrossRef]
  123. Ramtin, M.; Massiha, A.; Pahlavian, M.R.M.K.; Issazadeh, K.; Assmar, M.; Zarrabi, S. In Vitro Antimicrobial Activity of Iris Pseudacorus and Urtica dioica. Zahedan J. Res. Med. Sci. 2013, 16, 35–39. [Google Scholar]
  124. Elez Garofulić, I.; Malin, V.; Repajić, M.; Zorić, Z.; Pedisić, S.; Sterniša, M.; Smole Možina, S.; Dragović-Uzelac, V. Phenolic Profile, Antioxidant Capacity and Antimicrobial Activity of Nettle Leaves Extracts Obtained by Advanced Extraction Techniques. Molecules 2021, 26, 6153. [Google Scholar] [CrossRef] [PubMed]
  125. Azizi Alidoust, F.; Anvari, M.; Ataei Jaliseh, S. Antimicrobial Activity of Aqueous and Alcoholic Extracts of Chamomile, Fleawort, Aquatic Pennyroyal and Nettle Plants on Klebsiella Pneumoniae and Comparing Their Effects with Common Antibiotics. Iran. J. Med. Microbiol. 2020, 14, 361–373. [Google Scholar] [CrossRef]
  126. Shabani, M.; Ghorbani-HasanSaraei, A.; Shariatifar, N.; Savadkoohi, F.; Shahidi, S.-A. Effect of Urtica dioica L. Essential Oil (Forms of Free and Nanoliposome) on Some Inoculated Pathogens (Escherichia coli and Listeria monocytogenes) in Minced Camel Meat. Food Chem. X 2023, 20, 101050. [Google Scholar] [CrossRef] [PubMed]
  127. Khan, M.Z.; Azad, A.K.; Jan, S.; Safdar, M.; Bibi, S.; Majid, A.M.S.A.; Albadrani, G.M.; Nouh, N.A.T.; Abdulhakim, J.A.; Abdel-Daim, M.M. An Experimental and Computational Analysis of Plant Compounds from Whole Urtica dioica L. Plant’s Essential Oil for Antioxidant and Antibacterial Activities. Metabolites 2023, 13, 502. [Google Scholar] [CrossRef] [PubMed]
  128. Mannila, E.; Marti-Quijal, F.J.; Selma-Royo, M.; Calatayud, M.; Falcó, I.; de la Fuente, B.; Barba, F.J.; Collado, M.C.; Linderborg, K.M. In Vitro Bioactivities of Food Grade Extracts from Yarrow (Achillea millefolium L.) and Stinging Nettle (Urtica dioica L.) Leaves. Plant Foods Hum. Nutr. 2023, 78, 132–138. [Google Scholar] [CrossRef] [PubMed]
  129. Rolta, R.; Kumar, V.; Sourirajan, A.; Upadhyay, N.; Dev, K. Phytocompounds Of Three Medicinal Plants (Juniperus communis, Urtica dioica and Coleus forskohlii) of North West Himalayas Increases the Potency of Antibacterial and Antifungal Antibiotics. Plant Arch. 2020, 20, 481–489. [Google Scholar]
  130. Mukherjee, P.K.; Efferth, T.; Das, B.; Kar, A.; Ghosh, S.; Singha, S.; Debnath, P.; Sharma, N.; Bhardwaj, P.K.; Haldar, P.K. Role of Medicinal Plants in Inhibiting SARS-CoV-2 and in the Management of Post-COVID-19 Complications. Phytomedicine 2022, 98, 153930. [Google Scholar] [CrossRef] [PubMed]
  131. Barre, A.; Van Damme, E.J.M.; Simplicien, M.; Le Poder, S.; Klonjkowski, B.; Benoist, H.; Peyrade, D.; Rougé, P. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives. Cells 2021, 10, 1619. [Google Scholar] [CrossRef] [PubMed]
  132. Kumaki, Y.; Wandersee, M.K.; Smith, A.J.; Zhou, Y.; Simmons, G.; Nelson, N.M.; Bailey, K.W.; Vest, Z.G.; Li, J.K.-K.; Chan, P.K.-S.; et al. Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication in a Lethal SARS-CoV BALB/c Mouse Model by Stinging Nettle Lectin, Urtica dioica Agglutinin. Antivir. Res 2011, 90, 22–32. [Google Scholar] [CrossRef] [PubMed]
  133. Wang, X.; Terrie, L.; Wu, G.; Van Damme, E.J.M.; Thorrez, L.; Fooks, A.R.; Banyard, A.C.; Jochmans, D.; Neyts, J. Urtica dioica Agglutinin Prevents Rabies Virus Infection in a Muscle Explant Model. Pharmaceutics 2023, 15, 1353. [Google Scholar] [CrossRef] [PubMed]
  134. Badirzadeh, A.; Heidari-Kharaji, M.; Fallah-Omrani, V.; Dabiri, H.; Araghi, A.; Chirani, A.S. Antileishmanial Activity of Urtica dioica Extract against Zoonotic Cutaneous Leishmaniasis. PLoS Neglected Trop. Dis. 2020, 14, e0007843. [Google Scholar] [CrossRef] [PubMed]
  135. Peyvandi, A.; Gorgani-Firouzjaee, T.; Najafzadehvarzi, H.; Jafarzadeh, J. Urtica dioica Extract Leads to Cyst Reduction, Enhanced Cell-Mediated Immune Response, and Antioxidant Activity in Experimental Toxoplasmosis. Acta Parasit. 2023, 68, 880–890. [Google Scholar] [CrossRef] [PubMed]
  136. Hajhashemi, V.; Klooshani, V. Antinociceptive and Anti-Inflammatory Effects of Urtica dioica Leaf Extract in Animal Models. Avicenna J. Phytomed. 2013, 3, 193–200. [Google Scholar] [PubMed]
  137. Riehemann, K.; Behnke, B.; Schulze-Osthoff, K. Plant Extracts from Stinging Nettle (Urtica dioica), an Antirheumatic Remedy, Inhibit the Proinflammatory Transcription Factor NF-κB. FEBS Lett. 1999, 442, 89–94. [Google Scholar] [CrossRef]
  138. Shakibaei, M.; Allaway, D.; Nebrich, S.; Mobasheri, A. Botanical Extracts from Rosehip (Rosa Canina), Willow Bark (Salix Alba), and Nettle Leaf (Urtica dioica) Suppress IL-1 β-Induced NF-κB Activation in Canine Articular Chondrocytes. Evid.-Based Complement. Altern. Med. 2012, 2012, 509383. [Google Scholar] [CrossRef]
  139. Johnson, T.A.; Sohn, J.; Inman, W.D.; Bjeldanes, L.F.; Rayburn, K. Lipophilic Stinging Nettle Extracts Possess Potent Anti-Inflammatory Activity, Are Not Cytotoxic and May Be Superior to Traditional Tinctures for Treating Inflammatory Disorders. Phytomedicine 2013, 20, 143–147. [Google Scholar] [CrossRef]
  140. Obertreis, B.; Giller, K.; Teucher, T.; Behnke, B.; Schmitz, H. Original title: Antiphlogistische Effekte von Extractum Urticae dioicae foliorum im Vergleich zu Kaffeoyläpfelsäure [Anti-inflammatory effect of Urtica dioica folia extract in comparison to caffeic malic acid]. Arzneimittelforschung 1996, 46, 52–56. [Google Scholar] [PubMed]
  141. Nematgorgani, S.; Agah, S.; Shidfar, F.; Janani, L.; Faghihi, A.; Hosseini, S. The Effect of Urtica dioica Leaf Extract Intake on Serum TNF-α, Stool Calprotectin and Erythrocyte Sedimentation Rate in Patients with Inflammatory Bowel Disease: A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial. Mediterr. J. Nutr. Metab. 2020, 13, 75–87. [Google Scholar] [CrossRef]
  142. Abd-Nikfarjam, B.; Abbasi, M.; Memarzadeh, M.; Farzam, S.-A.; Jamshidian, A.; Dolati-Somarin, A. Therapeutic Efficacy of Urtica dioica and Evening Primrose in Patients with Rheumatoid Arthritis: A Randomized Double-Blind, Placebo-Controlled Clinical Trial. J. Herb. Med. 2022, 32, 100556. [Google Scholar] [CrossRef]
  143. Bakhshaee, M.; Pour, A.H.M.; Esmaeili, M.; Azad, F.J.; Talesh, G.A.; Salehi, M.; Mohajer, M.N. Efficacy of Supportive Therapy of Allergic Rhinitis by Stinging Nettle (Urtica dioica) Root Extract: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Iran. J. Pharm. Res. 2017, 16, 112–118. [Google Scholar] [PubMed]
  144. Vogel, H.G.; Vogel, W.H. Drug Discovery and Evaluation: Pharmacological Assays; Springer: Berlin/Heidelberg, Germany, 1997; ISBN 978-3-540-60291-0. [Google Scholar]
  145. ESCOP. 2nd Edition of the ESCOP Monographs: Two Volume; ESCOP: Lüneburg, Germany, 2010. [Google Scholar]
  146. Randall, C.; Meethan, K.; Randall, H.; Dobbs, F. Nettle Sting of Urtica dioica for Joint Pain—An Exploratory Study of This Complementary Therapy. Complement. Ther. Med. 1999, 7, 126–131. [Google Scholar] [CrossRef] [PubMed]
  147. Gao, B.; Jeong, W.-I.; Tian, Z. Liver: An Organ with Predominant Innate Immunity. Hepatology 2008, 47, 729–736. [Google Scholar] [CrossRef]
  148. Özkol, H.; Musa, D.; Tuluce, Y.; Koyuncu, I. Ameliorative Influence of Urtica dioica L against Cisplatin-Induced Toxicity in Mice Bearing Ehrlich Ascites Carcinoma. Drug Chem. Toxicol. 2012, 35, 251–257. [Google Scholar] [CrossRef] [PubMed]
  149. Al-Akash, M.A.; Rajab, H.A.; Al-Assaf, I.N. Protective Effect of Urtica dioica in Liver and Kidney Damages Induce by Ethylene Glycol in Rabbits: A Histopathological Study. Iraqi J. Vet. Sci. 2021, 36, 167–170. [Google Scholar] [CrossRef]
  150. Valavanidis, A.; Vlachogianni, T.; Fiotakis, C. 8-Hydroxy-2′-Deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis. J. Environ. Sci. Health Part C 2009, 27, 120–139. [Google Scholar] [CrossRef] [PubMed]
  151. Deshpande, K.C.; Kulkarni, M.M.; Rajput, D.V. Evaluation of Glutathione Peroxidase in the Blood and Tumor Tissue of Oral Squamous Cell Carcinoma Patients. J. Oral Maxillofac. Pathol. 2018, 22, 447. [Google Scholar] [CrossRef] [PubMed]
  152. Çakır, T.; Yıldızhan, K.; Huyut, Z.; Uyar, A.; Arıhan, O. Radioprotective Profile of Urtica dioica L. Seed Extract on Oxidative DNA-Damage in Liver Tissue and Whole Blood of Radiation-Administered Rats. Braz. J. Pharm. Sci. 2020, 56, e18382. [Google Scholar] [CrossRef]
  153. Yıldızhan, K.; Demirtaş, Ö.C.; Uyar, A.; Huyut, Z.; Çakir, T.; Keleş, Ö.F.; Yener, Z. Protective Effects of Urtica dioica L. Seed Extract on Liver Tissue Injury and Antioxidant Capacity in Irradiated Rats. Braz. J. Pharm. Sci. 2020, 56, e18354. [Google Scholar] [CrossRef]
  154. Ferubko, E.V.; Nikolaev, S.M.; Dargaeva, T.D.; Rendyuk, T.D. Correction of Toxic Liver Damage with a Multicomponent Herbal Extract in an Animal Experiment. Pharmacogn. J. 2020, 12, 168–172. [Google Scholar] [CrossRef]
  155. Barboiu, G.; Radulescu, C.; Popescu, I.; Dulama, I.; Bucurică, I.; Slămnoiu-Teodorescu, S.; Ştirbescu, R.-M.; Stirbescu, N.-M.; Tanase, N. Potential Health Risk Assessment Associated with Heavy Metal Accumulation in Native Urtica dioica. Rom. Rep. Phys. 2020, 72, 711. [Google Scholar]
  156. Singh, M.P.; Priyadarshi, P.; Jaiswal, S.; Adity; Singh, N. Occurrence and Toxicities of Heavy Metals: Amelioration by Asparagus racemosus & Urtica diocia. Plant Arch. 2020, 20, 2562–2570. [Google Scholar]
  157. Aldulaimi, A.M.A.; Jumaily, A.-A.I.H.A.; Husain, F.F. The Effect of Aqueous Urtica dioica Extract in Male Rats Exposed to Copper Sulfate Poisoning. IOP Conf. Ser. Earth Environ. Sci. 2021, 735, 012008. [Google Scholar] [CrossRef]
  158. Yilmaz, B.; Basar, Ö.; Aktas, B.; Altinbas, A.; Ekiz, F.; Büyükcam, F.; Albayrak, A.; Ginis, Z.; Öztürk, G.; Coban, S.; et al. Effects of Urtica dioica Extract on Experimental Acute Pancreatitis Model in Rats. Int. J. Clin. Exp. Med. 2014, 7, 1313–1318. [Google Scholar]
  159. Danon, J.J.; Reekie, T.A.; Kassiou, M. Challenges and Opportunities in Central Nervous System Drug Discovery. Trends Chem. 2019, 1, 612–624. [Google Scholar] [CrossRef]
  160. Beygi, M.; Oroojalian, F.; Azizi-Arani, S.; Hosseini, S.S.; Mokhtarzadeh, A.; Kesharwani, P.; Sahebkar, A. Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier. Adv. Funct. Mater. 2024, 34, 2310881. [Google Scholar] [CrossRef]
  161. Ano, Y.; Kita, M.; Kitaoka, S.; Furuyashiki, T. Leucine–Histidine Dipeptide Attenuates Microglial Activation and Emotional Disturbances Induced by Brain Inflammation and Repeated Social Defeat Stress. Nutrients 2019, 11, 2161. [Google Scholar] [CrossRef] [PubMed]
  162. de Munter, J.; Pavlov, D.; Gorlova, A.; Sicker, M.; Proshin, A.; Kalueff, A.V.; Svistunov, A.; Kiselev, D.; Nedorubov, A.; Morozov, S.; et al. Increased Oxidative Stress in the Prefrontal Cortex as a Shared Feature of Depressive- and PTSD-Like Syndromes: Effects of a Standardized Herbal Antioxidant. Front. Nutr. 2021, 8, 661455. [Google Scholar] [CrossRef]
  163. Patel, S.S.; Udayabanu, M. Effect of Urtica dioica on Memory Dysfunction and Hypoalgesia in an Experimental Model of Diabetic Neuropathy. Neurosci. Lett. 2013, 552, 114–119. [Google Scholar] [CrossRef] [PubMed]
  164. Mahmoud, A.A.; Zayed Mohamed, M.; Hassen, E.Z. Protective Effects of Urtica dioica on the Cerebral Cortex Damage Induced by Potassium Bromate in Adult Male Albino Rats. Ultrastruct. Pathol. 2024, 48, 81–93. [Google Scholar] [CrossRef] [PubMed]
  165. Keshvari, M.; Rahmati, M.; Mirnasouri, R.; Chehelcheraghi, F. Effects of Endurance Exercise and Urtica dioica on the Functional, Histological and Molecular Aspects of the Hippocampus in STZ-Induced Diabetic Rats. J. Ethnopharmacol. 2020, 256, 112801. [Google Scholar] [CrossRef]
  166. Abu Almaaty, A.H.; Mosaad, R.M.; Hassan, M.K.; Ali, E.H.A.; Mahmoud, G.A.; Ahmed, H.; Anber, N.; Alkahtani, S.; Abdel-Daim, M.M.; Aleya, L.; et al. Urtica dioica Extracts Abolish Scopolamine-Induced Neuropathies in Rats. Environ. Sci. Pollut. Res. 2021, 28, 18134–18145. [Google Scholar] [CrossRef] [PubMed]
  167. Rahmati, M.; Keshvari, M.; Xie, W.; Yang, G.; Jin, H.; Li, H.; Chehelcheraghi, F.; Li, Y. Resistance Training and Urtica dioica Increase Neurotrophin Levels and Improve Cognitive Function by Increasing Age in the Hippocampus of Rats. Biomed. Pharmacother. 2022, 153, 113306. [Google Scholar] [CrossRef] [PubMed]
  168. Albadawi, E.; El-Tokhy, A.; Albadrani, M.; Adel, M.; El-Gamal, R.; Zaarina, W.; El-Agawy, M.S.E.; Elsayed, H.R.H. The Role of Stinging Nettle (Urtica dioica L.) in the Management of Rotenone-Induced Parkinson’s Disease in Rats. Tissue Cell 2024, 87, 102328. [Google Scholar] [CrossRef]
  169. Tesfaye, S.; Selvarajah, D. Advances in the Epidemiology, Pathogenesis and Management of Diabetic Peripheral Neuropathy. Diabetes/Metab. Res. Rev. 2012, 28, 8–14. [Google Scholar] [CrossRef] [PubMed]
  170. Alsaidya, A.M.A.; Ismail, H.K.; Mostafa, E.S. Efficacy of Urtiea Dicica Extract for Amelioration of Brain Lesions Induced by Ethylene Glycol in Male Rabbits. Iraqi J. Vet. Sci. 2022, 36, 485–488. [Google Scholar] [CrossRef]
  171. Loshali, A.; Joshi, B.C.; Sundriyal, A.; Uniyal, S. Antiepileptic Effects of Antioxidant Potent Extract from Urtica dioica Linn. Root on Pentylenetetrazole and Maximal Electroshock Induced Seizure Models. Heliyon 2021, 7, e06195. [Google Scholar] [CrossRef] [PubMed]
  172. Manville, R.W.; Alfredo Freites, J.; Sidlow, R.; Tobias, D.J.; Abbott, G.W. Native American Ataxia Medicines Rescue Ataxia-Linked Mutant Potassium Channel Activity via Binding to the Voltage Sensing Domain. Nat. Commun. 2023, 14, 3281. [Google Scholar] [CrossRef] [PubMed]
  173. Hedayati, M.; Abedinzade, M.; Khanaki, K.; Khakpour, B.; Golshekan, M.; Mohammadi, E. Comparative Protective Effects of Viola Spathulata, Urtica dioica, and Lamium Album on Endoplasmic Reticulum (ER) Stress in Rat Stroke Model. Casp. J. Neurol. Sci. 2021, 7, 172–179. [Google Scholar] [CrossRef]
  174. Testai, L.; Chericoni, S.; Calderone, V.; Nencioni, G.; Nieri, P.; Morelli, I.; Martinotti, E. Cardiovascular Effects of Urtica dioica L. (Urticaceae) Roots Extracts: In Vitro and in Vivo Pharmacological Studies. J. Ethnopharmacol. 2002, 81, 105–109. [Google Scholar] [CrossRef]
  175. Legssyer, A.; Ziyyat, A.; Mekhfi, H.; Bnouham, M.; Tahri, A.; Serhrouchni, M.; Hoerter, J.; Fischmeister, R. Cardiovascular Effects of Urtica dioica L. in Isolated Rat Heart and Aorta. Phytother. Res. 2002, 16, 503–507. [Google Scholar] [CrossRef]
  176. Sidhu, S.; Marine, J.E. Evaluating and Managing Bradycardia. Trends Cardiovasc. Med. 2020, 30, 265–272. [Google Scholar] [CrossRef]
  177. Kathak, R.R.; Sumon, A.H.; Molla, N.H.; Hasan, M.; Miah, R.; Tuba, H.R.; Habib, A.; Ali, N. The Association between Elevated Lipid Profile and Liver Enzymes: A Study on Bangladeshi Adults. Sci. Rep. 2022, 12, 1711. [Google Scholar] [CrossRef] [PubMed]
  178. Alisi, C.S.; Mejulu, A.; Alisi, P.; Nwaogu, L.; Onyema, O. Decreased Cardiovascular Risk and Resistance to Hyperlipemia-Induced Hepatic Damage in Rats by Aqueous Extract of Urtica dioica. Afr. J. Biochem. Res. 2008, 2, 102–106. Available online: http://www.academicjournals.org/AJBR (accessed on 3 June 2024).
  179. El Haouari, M.; Bnouham, M.; Bendahou, M.; Aziz, M.; Ziyyat, A.; Legssyer, A.; Mekhfi, H. Inhibition of Rat Platelet Aggregation by Urtica dioica Leaves Extracts. Phytother. Res. 2006, 20, 568–572. [Google Scholar] [CrossRef] [PubMed]
  180. Shamsi, M.; Ganji, A.; Mosayebi, G.; Amirhoseiny, E.S.; Shohani, S.; Ghazavi, A. Chamomile and Urtica dioica Extracts Improve Immunological and Histological Alterations Associated with Polycystic Ovarian Syndrome in DHEA -Induced Mice. BMC Complement. Med. Ther. 2023, 23, 102. [Google Scholar] [CrossRef]
  181. Bandariyan, E.; Mogheiseh, A.; Ahmadi, A. The Effect of Lutein and Urtica dioica Extract on in Vitro Production of Embryo and Oxidative Status in Polycystic Ovary Syndrome in a Model of Mice. BMC Complement. Med. Ther. 2021, 21, 55. [Google Scholar] [CrossRef]
  182. Jasim, S.A.; Ali, S.A.J.; Fadhil, O.Q.; Rakhmatova, M.K.; Kzar, H.H.; Margiana, R.; Al-Gazally, M.E.; Jalil, A.T.; Mahmood, Z.H.; Aravindhan, S.; et al. Investigating the Effects of Hydro-Alcoholic Urtica dioica Extract and Retinoic Acid on Follicular Development: An Animal Study. Med. J. Islam. Repub. Iran 2023, 37, 1. [Google Scholar] [CrossRef]
  183. Du, S.; Wang, L.; Wang, Y.; Jin, Y.; Wang, A.; Lv, C.; Abedi-Firouzjah, R. The Modulator Role of Urtica dioica on Deleterious Effects of Retinoic Acid High Doses on Histological Parameters and Fertilization of Rats. Heliyon 2023, 9, e17277. [Google Scholar] [CrossRef]
  184. Oladimeji, S.O.; Soares, A.S.; Igbalaye, J.O.; Awote, O.K.; Adigun, A.K.; Awoyemi, Z.O. Ethanolic Root Extract of Urtica dioica Exhibits Pro-Fertility and Antioxidant Activities in Female Albino Rats. Int. J. Biochem. Res. Rev. 2022, 31, 29–38. [Google Scholar] [CrossRef]
  185. Sharokhyan Rezaee, M.; Farzinpour, A.; Farshad, A.; Hatfaludi, T. The Regulative Effect of Urtica dioica on Sex Hormones Imbalance: Elevated Follicle-Stimulating Hormone/Luteinizing Hormone Ratio ≥4.5 Is Associated with Low Performance in Aged Breeder Quails. Ital. J. Anim. Sci. 2022, 21, 142–152. [Google Scholar] [CrossRef]
  186. Kargozar, R.; Salari, R.; Jarahi, L.; Yousefi, M.; Pourhoseini, S.A.; Sahebkar-Khorasani, M.; Azizi, H. Urtica dioica in Comparison with Placebo and Acupuncture: A New Possibility for Menopausal Hot Flashes: A Randomized Clinical Trial. Complement. Ther. Med. 2019, 44, 166–173. [Google Scholar] [CrossRef] [PubMed]
  187. Rouhi-Boroujeni, H.; Heidarian, E.; Rouhi-Boroujeni, H.; Khoddami, M.; Gharipour, M.; Rafieian-Kopaei, M. Use of Lipid-Lowering Medicinal Herbs during Pregnancy: A Systematic Review on Safety and Dosage. ARYA Atheroscler. 2017, 13, 135–155. [Google Scholar]
  188. Urticae Herba—Herbal Medicinal Product|European Medicines Agency. 2005. Available online: https://www.ema.europa.eu/en/medicines/herbal/urticae-herba#documents (accessed on 2 July 2024).
  189. Stinging Nettle. Drugs and Lactation Database (LactMed®); National Institute of Child Health and Human Development: Bethesda, MD, USA, 2006.
  190. Jalili, C.; Salahshoor, M.R.; Naseri, A. Protective Effect of Urtica dioica L against Nicotine-Induced Damage on Sperm Parameters, Testosterone and Testis Tissue in Mice. Iran. J. Reprod. Med. 2014, 12, 401–408. [Google Scholar] [PubMed]
  191. Gülçin, İ.; Küfrevioǧlu, Ö.İ.; Oktay, M.; Büyükokuroǧlu, M.E. Antioxidant, Antimicrobial, Antiulcer and Analgesic Activities of Nettle (Urtica dioica L.). J. Ethnopharmacol. 2004, 90, 205–215. [Google Scholar] [CrossRef] [PubMed]
  192. Konrad, A.; Mähler, M.; Arni, S.; Flogerzi, B.; Klingelhöfer, S.; Seibold, F. Ameliorative Effect of IDS 30, a Stinging Nettle Leaf Extract, on Chronic Colitis. Int. J. Colorectal. Dis. 2005, 20, 9–17. [Google Scholar] [CrossRef] [PubMed]
  193. Dakhli, N.; Rtibi, K.; Arrari, F.; Ayari, A.; Sebai, H. Prophylactic Coloprotective Effect of Urtica dioica Leaves against Dextran Sulfate Sodium (DSS)-Induced Ulcerative Colitis in Rats. Medicina 2023, 59, 1990. [Google Scholar] [CrossRef] [PubMed]
  194. Fan, S.; Raychaudhuri, S.; Page, R.; Shahinozzaman, M.; Obanda, D.N. Metagenomic Insights into the Effects of Urtica dioica Vegetable on the Gut Microbiota of C57BL/6J Obese Mice, Particularly the Composition of Clostridia. J. Nutr. Biochem. 2021, 91, 108594. [Google Scholar] [CrossRef] [PubMed]
  195. Perna, S.; Biserni, M.; Borsani, F.; Berardi, M.; Spadaccini, D.; Rondanelli, M. Effect of a Mixture of Botanicals Extracts plus Mannitol on Hydration and Bloating Sensation. An Open Label Study in Women with High Extra Cellular Water. Nat. Prod. Res. 2020, 34, 2500–2504. [Google Scholar] [CrossRef] [PubMed]
  196. Nematgorgani, S.; Agah, S.; Shidfar, F.; Gohari, M.; Faghihi, A. Effects of Urtica dioica Leaf Extract on Inflammation, Oxidative Stress, ESR, Blood Cell Count and Quality of Life in Patients with Inflammatory Bowel Disease. J. Herb. Med. 2017, 9, 32–41. [Google Scholar] [CrossRef]
  197. Keleş, R.; Sen, A.; Ertas, B.; Kayalı, D.; Eker, P.; Sener, T.E.; Doğan, A.; Cetinel, S.; Sener, G. The Effects of Urtica dioica L. Ethanolic Extract against Urinary Calculi in Rats. Marmara Pharm. J. 2020, 24, 205–217. [Google Scholar] [CrossRef]
  198. Maisto, M.; Schiano, E.; Luccheo, G.; Luccheo, L.; Alfieri, E.; Piccolo, V.; Iannuzzo, F.; Di Lorenzo, R.; Tenore, G.C. Efficacy of a Multicomponent Nutraceutical Formulation for the Prevention and Treatment of Urinary Tract Stones. Int. J. Mol. Sci. 2023, 24, 8316. [Google Scholar] [CrossRef] [PubMed]
  199. Mahboubi, M. Urtica dioica in the Management of Benign Prostate Hyperplasia (BPH). Nat. Prod. J. 2020, 10, 535–542. [Google Scholar] [CrossRef]
  200. Safarinejad, M.R. Urtica dioica for Treatment of Benign Prostatic Hyperplasia: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study. J. Herb. Pharmacother. 2005, 5, 1–11. [Google Scholar] [CrossRef] [PubMed]
  201. Akbar Karami, A.; Sheikhsole, M.; Reza Memar, M.; Haddadi, E.; Bakhshpour, M.; Mohammadi, N.; Mehdi Mirh, S. Urtica dioica Root Extract on Clinical and Biochemical Parameters in Patients with Benign Prostatic Hyperplasia, Randomized Controlled Trial. Pak. J. Biol. Sci. 2020, 23, 1338–1344. [Google Scholar] [CrossRef]
  202. Moradi, H.R.; Erfani Majd, N.; Esmaeilzadeh, S.; Fatemi Tabatabaei, S.R. The Histological and Histometrical Effects of Urtica dioica Extract on Rat’s Prostate Hyperplasia. Vet. Res. Forum 2015, 6, 23–29. [Google Scholar] [PubMed]
  203. Ghorbanibirgani, A.; Khalili, A.; Zamani, L. The Efficacy of Stinging Nettle (Urtica dioica) in Patients with Benign Prostatic Hyperplasia: A Randomized Double-Blind Study in 100 Patients. Iran. Red. Crescent. Med. J. 2013, 15, 9–10. [Google Scholar] [CrossRef] [PubMed]
  204. Men, C.; Wang, M.; Aiyireti, M.; Cui, Y. The Efficacy and Safety of Urtica dioica in Treating Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Afr. J. Tradit. Complement. Altern. Med. 2016, 13, 143–150. [Google Scholar] [CrossRef]
  205. Kirschner-Hermanns, R.; Funk, P.; Leistner, N. WS PRO 160 I 120 Mg (a Combination of Sabal and Urtica Extract) in Patients with LUTS Related to BPH. Ther. Adv. Urol. 2019, 11, 1756287219879533. [Google Scholar] [CrossRef]
  206. Sökeland, J. Combined Sabal and Urtica Extract Compared with Finasteride in Men with Benign Prostatic Hyperplasia: Analysis of Prostate Volume and Therapeutic Outcome. BJU Int. 2000, 86, 439–442. [Google Scholar] [CrossRef]
  207. Oelke, M.; Berges, R.; Schläfke, S.; Burkart, M. Fixed-Dose Combination PRO 160/120 of Sabal and Urtica Extracts Improves Nocturia in Men with LUTS Suggestive of BPH: Re-Evaluation of Four Controlled Clinical Studies. World J. Urol. 2014, 32, 1149–1154. [Google Scholar] [CrossRef] [PubMed]
  208. Schöttner, M.; Gansser, D.; Spiteller, G. Lignans from the Roots of Urtica dioica and Their Metabolites Bind to Human Sex Hormone Binding Globulin (SHBG). Planta Med. 1997, 63, 529–532. [Google Scholar] [CrossRef] [PubMed]
  209. Hryb, D.J.; Khan, M.S.; Romas, N.A.; Rosner, W. The Effect of Extracts of the Roots of the Stinging Nettle (Urtica dioica) on the Interaction of SHBG with Its Receptor on Human Prostatic Membranes. Planta Med. 1995, 61, 31–32. [Google Scholar] [CrossRef] [PubMed]
  210. Saponaro, M.; Giacomini, I.; Morandin, G.; Cocetta, V.; Ragazzi, E.; Orso, G.; Carnevali, I.; Berretta, M.; Mancini, M.; Pagano, F.; et al. Serenoa Repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH). Int. J. Mol. Sci. 2020, 21, 9178. [Google Scholar] [CrossRef] [PubMed]
  211. Cai, T.; Anceschi, U.; Tamanini, I.; Verze, P.; Palmieri, A. Soybean Extracts (Glycine Max) with Curcuma, Boswellia, Pinus and Urtica Are Able to Improve Quality of Life in Patients Affected by CP/CPPS: Is the Pro-Inflammatory Cytokine IL-8 Level Decreasing the Physiopathological Link? Uro 2022, 2, 40–48. [Google Scholar] [CrossRef]
Figure 1. Overview of the chemical composition of the nettle plant.
Figure 1. Overview of the chemical composition of the nettle plant.
Ijms 25 07501 g001
Figure 2. Overview of the anticancer properties of the nettle plant (↑: increase ↓: decrease).
Figure 2. Overview of the anticancer properties of the nettle plant (↑: increase ↓: decrease).
Ijms 25 07501 g002
Figure 3. Overview of the nettle plant’s antidiabetic, microbial, and inflammatory properties and protective effects on the liver, reproductive, excretory, cardiovascular, nervous, and digestive systems (↑: increase, ↓: decrease).
Figure 3. Overview of the nettle plant’s antidiabetic, microbial, and inflammatory properties and protective effects on the liver, reproductive, excretory, cardiovascular, nervous, and digestive systems (↑: increase, ↓: decrease).
Ijms 25 07501 g003
Table 1. The taxonomic classification of the nettle plant.
Table 1. The taxonomic classification of the nettle plant.
KingdomPlantae
DivisionMagnoliophyta
ClassMagnoliopsida
OrderRosales
FamilyUrticaceae
GenusUrtica
SpeciesUrtica dioica
Table 2. Overview of the in vitro apoptotic mechanisms taking place in various cancer cell lines.
Table 2. Overview of the in vitro apoptotic mechanisms taking place in various cancer cell lines.
Cancer TypeCancer Cell LineApoptosisOutcomeReferences
Prostate cancerLNCaPNot reported⇩ Cellular proliferation[52]
Prostate cancerProstate tissue from prostate cancer patientsIncreases⇩ ADA[59]
Prostate cancerPC3Increases⇧ Caspase 3
⇧ Caspase 9
⇩ Bcl-2
⇧ G2/M arrest
[50]
Prostate cancerLNCaPIncreases⇧ Caspase 3
⇧ Caspase 9
⇧ ROS
[51]
Breast cancerMCF-7Increases⇧ Calcium overload
⇧ Caspase 3 & 9
⇧ BAX/BCL2
⇧ DNA fragmentation
[60]
Breast cancerMCF-7 &
MDA-MB-231
Increases⇩ MMP-1, 9, &13
⇩ miR-21
⇩ CXCR4
⇧ E-cadherin
⇩ Vimentin
[66]
Breast cancerMDA-MB-468Increases⇧ Pre-G0 cycle arrest
⇧ BAX/BCL2
⇩ Snail-1 gene
⇧ G2/M cycle arrest
⇩ Cdc2 and wee1
[67]
Breast cancerMDA-MB-231Increases⇧ A2B receptor activity
⇩ RAS-ERK signaling
⇩ MAPK
⇧ ODC1 overexpression
⇩P53
[62]
Blood cancerHL-60 (AML)Increases⇧ G0/G1 cycle arrest
⇧ p27
⇩ p53
⇧ Mitochondrial membrane potential
⇧ Caspase 3, 8, & 9
⇧ BAX/BCL2
⇧ PTEN
⇧ BECLIN1 & LC3
[74]
Blood cancerHL-60 (AML)Increases⇧ Sub-G1 cycle arrest
⇧ Caspases 3, 8, & 9
⇩ MDM2/MDM4
⇩ IGF1/IGF1R
⇩ PARP1
⇩ PARP2
⇧ PARP4
[78]
Blood cancerU937 (AML)Increases⇧ Pre-G0 cycle arrest
⇧ Bax/Bcl2
[75]
Blood cancerJurkat (ALL)Increases⇧ Caspases 3, 8, & 9[77]
Blood cancerRaji (ALL)Not detected⇩ Cell proliferation[77]
Colorectal cancerHCT116Increases⇧ G2/M cycle arrest
⇧ Caspases 3 & 9
⇩ Bcl-2
[81]
Colorectal cancerHCT116Increases⇧ Bax/Bcl-2[83]
Colorectal cancerHCT116 ⇧ Anticancer effect in combination with Wormwood extract[89]
Bladder cancerT24Increases⇧ Effect of Doxorubicin[91]
Lung cancerNSCLC
H460, H1299, A549, and H322
Increases⇧ GADD153
⇧ ER stress
⇧ G2/M cycle arrest
⇧ Effect of Cisplatin
[92]
⇧: increase, ⇩: decrease
Table 3. Overview of the antimicrobial properties of nettle plant.
Table 3. Overview of the antimicrobial properties of nettle plant.
Type of MicroorganismName of MicroorganismEffect of UD on the MicroorganismReferences
Pathogenic
Bacteria
Staphylococcus aureusAntibacterial[69,115,121,122,123,127,129]
Escherichia coli[69,115,122,126,127,129]
Bacillus subtilis[69,115,127]
Pseudomonas aeruginosa[69,115,123,127]
Salmonella typhi[115,127]
Listeria monocytogenes[126]
Klebsiella pneumonia[115,123,125,129]
Pseudomonas fragi[124]
Campylobacter jejuni[124]
Shigella dysenteriae[115]
Bacillus cerus[123]
Non-Pathogenic BacteriaLacticaseibacillus
Strains
No effect[128]
Bifidobacterium strains[128]
FungiCandida albicansAntifungal[69,117,129]
Aspergillus flavus[69,129]
Candida parapsilosis[117]
Candida lipolytica[115]
Aspergillus fumigatus[69]
Aspergillus niger[69]
VirusesSARS-CoV-2Antiviral[118,130,131]
Rabies[133]
ParasitesToxoplasma gondiiAntiparasitic[135]
Leishmania major[134]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Abi Sleiman, M.; Younes, M.; Hajj, R.; Salameh, T.; Abi Rached, S.; Abi Younes, R.; Daoud, L.; Doumiati, J.L.; Frem, F.; Ishak, R.; et al. Urtica dioica: Anticancer Properties and Other Systemic Health Benefits from In Vitro to Clinical Trials. Int. J. Mol. Sci. 2024, 25, 7501. https://doi.org/10.3390/ijms25137501

AMA Style

Abi Sleiman M, Younes M, Hajj R, Salameh T, Abi Rached S, Abi Younes R, Daoud L, Doumiati JL, Frem F, Ishak R, et al. Urtica dioica: Anticancer Properties and Other Systemic Health Benefits from In Vitro to Clinical Trials. International Journal of Molecular Sciences. 2024; 25(13):7501. https://doi.org/10.3390/ijms25137501

Chicago/Turabian Style

Abi Sleiman, Marc, Maria Younes, Roy Hajj, Tommy Salameh, Samir Abi Rached, Rimane Abi Younes, Lynn Daoud, Jean Louis Doumiati, Francesca Frem, Ramza Ishak, and et al. 2024. "Urtica dioica: Anticancer Properties and Other Systemic Health Benefits from In Vitro to Clinical Trials" International Journal of Molecular Sciences 25, no. 13: 7501. https://doi.org/10.3390/ijms25137501

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop